<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25093715</article-id><article-id pub-id-type="pmc">4159807</article-id><article-id pub-id-type="doi">10.3390/ijms150813494</article-id><article-id pub-id-type="publisher-id">ijms-15-13494</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Non-Coding RNAs and Lipid Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Smolle</surname><given-names>Elisabeth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haybaeck</surname><given-names>Johannes</given-names></name><xref rid="c1-ijms-15-13494" ref-type="corresp">*</xref></contrib><aff id="af1-ijms-15-13494">Institute of Pathology, Medical University Graz, Auenbruggerplatz 25, A-8036 Graz, Austria; E-Mail: <email>elisabeth.smolle@stud.medunigraz.at</email></aff></contrib-group><author-notes><corresp id="c1-ijms-15-13494"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>johannes.haybaeck@medunigraz.at</email>; Tel.: +43-316-385-80594; Fax: +43-316-380-4403.</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>8</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2014</year></pub-date><volume>15</volume><issue>8</issue><fpage>13494</fpage><lpage>13513</lpage><history><date date-type="received"><day>14</day><month>6</month><year>2014</year></date><date date-type="rev-recd"><day>14</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2014</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>A high percentage of the mammalian genome consists of non-coding RNAs (ncRNAs). Among ncRNAs two main subgroups have been identified: long ncRNAs (lncRNAs) and micro RNAs (miRNAs). ncRNAs have been demonstrated to play a role in a vast variety of diseases, since they regulate gene transcription and are involved in post-transcriptional regulation. They have the potential to function as molecular signals or as guides for transcription factors and to regulate epigenetic modifiers. In this literature review we have summarized data on miRNAs and lncRNAs and their involvement in dyslipidaemia, atherosclerosis, insulin resistance and adipogenesis. Outlining certain ncRNAs as disease biomarkers and/or therapeutic targets, and testing them <italic>in vivo</italic>, will be the next steps in future research.</p></abstract><kwd-group><kwd>non-coding RNAs</kwd><kwd>micro RNAs</kwd><kwd>long non-coding RNAs</kwd><kwd>dyslipidaemia</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>A large percentage of the mammalian genome consists of non-coding RNAs (ncRNAs) [<xref rid="B1-ijms-15-13494" ref-type="bibr">1</xref>,<xref rid="B2-ijms-15-13494" ref-type="bibr">2</xref>,<xref rid="B3-ijms-15-13494" ref-type="bibr">3</xref>].</p><p>Among ncRNAs there are two main subgroups: long ncRNAs (lncRNAs) and micro RNAs (miRNAs). ncRNAs appear in many forms: they may be very short, or a few hundred kilobases in length. Some of them are spliced, whilst others are unspliced. ncRNAs can form linear or tertiary structures, and some of them interact with DNA, proteins or RNA [<xref rid="B4-ijms-15-13494" ref-type="bibr">4</xref>].</p><p>lncRNAs were initially discovered in the 1990s, when it was found that the lncRNA XIST (&#x0201c;X-chromosome inactivation&#x0201d;) inactivates the X-chromosome in females [<xref rid="B5-ijms-15-13494" ref-type="bibr">5</xref>,<xref rid="B6-ijms-15-13494" ref-type="bibr">6</xref>]. lncRNAs measure between 200 nucleotides and &#x0003e;100 kilobases, and they are commonly composed of one gene structure comprising up to 14 exons [<xref rid="B1-ijms-15-13494" ref-type="bibr">1</xref>,<xref rid="B7-ijms-15-13494" ref-type="bibr">7</xref>]. lncRNAs are produced either within their target gene or in the vicinity of the target gene; this is a key feature of lncRNAs [<xref rid="B8-ijms-15-13494" ref-type="bibr">8</xref>]. They are divided into five groups, corresponding to their association with mRNA: (1) sense; (2) antisense (the coding transcript and the lncRNA-transcript are reversed); (3) intronic (lncRNAs that stem from the introns of another transcript); (4) intergenic (lncRNAs located between two genes); (5) bidirectional (lncRNAs in the reverse direction with one or more exons in the same chain) [<xref rid="B9-ijms-15-13494" ref-type="bibr">9</xref>].</p><p>The number of lncRNAs in the genome is still debated, but it is estimated that there are &#x0003e;60,000 lncRNAs in the human genome [<xref rid="B10-ijms-15-13494" ref-type="bibr">10</xref>,<xref rid="B11-ijms-15-13494" ref-type="bibr">11</xref>]. Similarities between lncRNAs and protein-coding transcripts have been reported, e.g., lncRNAs are transcribed by RNA-polymerase [<xref rid="B12-ijms-15-13494" ref-type="bibr">12</xref>], they are spliced at canonical splicing sites [<xref rid="B13-ijms-15-13494" ref-type="bibr">13</xref>], are partly polyadenylated [<xref rid="B14-ijms-15-13494" ref-type="bibr">14</xref>] and associated with polysomes [<xref rid="B15-ijms-15-13494" ref-type="bibr">15</xref>]. By contrast, certain characteristics of lncRNAs differ from protein-coding genes: lncRNAs are expressed at lower levels, are less evolutionary conserved and less frequently associated with ribosomes compared to protein-coding transcripts [<xref rid="B10-ijms-15-13494" ref-type="bibr">10</xref>]. lncRNAs are known to regulate gene transcription and to be involved in post-transcriptional regulation. They have the potential to function as molecular signals or guides for transcription factors and to regulate epigenetic modifiers [<xref rid="B2-ijms-15-13494" ref-type="bibr">2</xref>]. lncRNAs themselves encode miRNAs and target certain mRNAs leading to RNA decay [<xref rid="B2-ijms-15-13494" ref-type="bibr">2</xref>]. It is suggested that lncRNAs play a role in gene expression changes in response to extracellular stimuli [<xref rid="B16-ijms-15-13494" ref-type="bibr">16</xref>,<xref rid="B17-ijms-15-13494" ref-type="bibr">17</xref>,<xref rid="B18-ijms-15-13494" ref-type="bibr">18</xref>,<xref rid="B19-ijms-15-13494" ref-type="bibr">19</xref>]. According to Wang <italic>et al.</italic> [<xref rid="B1-ijms-15-13494" ref-type="bibr">1</xref>], lncRNAs promote the timing of gene expression. Notably, some lncRNAs are able to generate small peptides and are thus acting as both, coding and non-coding, transcripts [<xref rid="B7-ijms-15-13494" ref-type="bibr">7</xref>].</p><p>miRNAs are short single-stranded ncRNAs, measuring between 19 and 25 nucleotides in length, and are well preserved in the eukaryotic genome [<xref rid="B20-ijms-15-13494" ref-type="bibr">20</xref>,<xref rid="B21-ijms-15-13494" ref-type="bibr">21</xref>]. miRNAs form base pairs with complementary loci within target mRNAs, and thereby negatively regulate gene expression via inhibition of translation and induction of specific mRNA degradation [<xref rid="B20-ijms-15-13494" ref-type="bibr">20</xref>,<xref rid="B22-ijms-15-13494" ref-type="bibr">22</xref>,<xref rid="B23-ijms-15-13494" ref-type="bibr">23</xref>]. Although miRNAs were discovered in the 1990s, they were not recognized as post-transcriptional regulators until the 2000s [<xref rid="B24-ijms-15-13494" ref-type="bibr">24</xref>,<xref rid="B25-ijms-15-13494" ref-type="bibr">25</xref>,<xref rid="B26-ijms-15-13494" ref-type="bibr">26</xref>,<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>]. miRNAs are potent endogenous regulators of gene expression, as every given miRNA has multiple gene targets [<xref rid="B28-ijms-15-13494" ref-type="bibr">28</xref>]. A single miRNA has the potential to regulate an entire cellular pathway, and any miRNA may contain multiple mRNA binding sites, which also contribute to miRNA-mediated gene silencing [<xref rid="B28-ijms-15-13494" ref-type="bibr">28</xref>]. Specific subsets of miRNAs are aberrantly expressed, dependent on the biological conditions in different tissues, meaning that regulation of gene expression by miRNAs is context-dependent [<xref rid="B28-ijms-15-13494" ref-type="bibr">28</xref>].</p><p>miRNAs are encoded by genes [<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>] and either transcribed from their own promoters or within a host protein-encoding gene [<xref rid="B20-ijms-15-13494" ref-type="bibr">20</xref>,<xref rid="B24-ijms-15-13494" ref-type="bibr">24</xref>,<xref rid="B29-ijms-15-13494" ref-type="bibr">29</xref>], mediated by RNA polymerase II, which leads to the formation of a primary miRNA transcript (pri-miRNA) [<xref rid="B24-ijms-15-13494" ref-type="bibr">24</xref>,<xref rid="B30-ijms-15-13494" ref-type="bibr">30</xref>]. Double-stranded pri-miRNA is then cleaved by a nuclear ribonuclease complex, generating a precursor miRNA (pre-miRNA) [<xref rid="B30-ijms-15-13494" ref-type="bibr">30</xref>,<xref rid="B31-ijms-15-13494" ref-type="bibr">31</xref>]. After that, the pre-miRNA is exported to the cytoplasm, where the pre-miRNA undergoes further enzymatic processing, and the final short double-stranded miRNA strand is generated [<xref rid="B32-ijms-15-13494" ref-type="bibr">32</xref>,<xref rid="B33-ijms-15-13494" ref-type="bibr">33</xref>,<xref rid="B34-ijms-15-13494" ref-type="bibr">34</xref>]. The miRNA seed region (nucleotides at position 2&#x02013;8) is involved in gene silencing, interacting with the target mRNA, which predominantly leads to a down-regulation of this target mRNA [<xref rid="B35-ijms-15-13494" ref-type="bibr">35</xref>,<xref rid="B36-ijms-15-13494" ref-type="bibr">36</xref>]. Circulating extracellular miRNAs, occurring stably in blood plasma without an association with cells, have been discovered [<xref rid="B37-ijms-15-13494" ref-type="bibr">37</xref>]. The levels of these extracellular miRNAs are associated with disease states [<xref rid="B37-ijms-15-13494" ref-type="bibr">37</xref>,<xref rid="B38-ijms-15-13494" ref-type="bibr">38</xref>,<xref rid="B39-ijms-15-13494" ref-type="bibr">39</xref>]. For example, extracellular miRNAs have been demonstrated to be associated with lipid-based carriers, such as high-density lipoproteins (HDLs) [<xref rid="B40-ijms-15-13494" ref-type="bibr">40</xref>,<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>]. HDLs contain miRNA signatures and miRNA profiles of HDL are altered in humans and mice suffering from cardiovascular disease [<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>].</p></sec><sec><title>2. In Depth Review of Existing Data</title><sec><title>2.1. Dyslipidaemia</title><p>miRNAs are associated with plasma HDL cholesterol, and HDL cholesterol levels are known to inversely correlate with cardiovascular diseases [<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>,<xref rid="B42-ijms-15-13494" ref-type="bibr">42</xref>]. HDL-association of miRNAs and the role of HDLs in miRNA transport link miRNAs to cardiovascular disease [<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>]. Cholesterol biosynthesis in the liver is important for the synthesis of lipids and lipoproteins in general, and for a proper function of lipid metabolism [<xref rid="B43-ijms-15-13494" ref-type="bibr">43</xref>,<xref rid="B44-ijms-15-13494" ref-type="bibr">44</xref>]. Recently, it has been demonstrated that miRNAs modulate these processes [<xref rid="B45-ijms-15-13494" ref-type="bibr">45</xref>,<xref rid="B46-ijms-15-13494" ref-type="bibr">46</xref>,<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>]. The <italic>miR-27b</italic> gene has been identified as a central candidate gene, regulating lipid metabolism post-translationally [<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>]. <italic>miR-27b</italic> was determined to target several lipid-associated genes in human hepatoma cell lines, for example heparan sulfate <italic>N</italic>-deacetylase/<italic>N</italic>-sulfotransferase 1 (<italic>NDST1</italic>), angiopoietin-like 3 (<italic>ANGPTL3</italic>), peroxisome proliferator-activated receptor &#x003b3; (<italic>PPARG</italic>) and glycerol-3-phosphate acyltransferase 1 (<italic>GPAM</italic>). Vickers and colleagues demonstrated that <italic>miR-27b</italic> and its target genes were significantly modulated in murine liver tissue, responding to diet-induced hyperlipidaemia [<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>]. As a reaction to elevated plasma triglycerides (TGs) and liver steatosis, hepatic <italic>miR-27b</italic> was significantly increased, and the ANGPTL3 and GPAM protein, being targets of <italic>miR-27b</italic>, were significantly repressed [<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>]. As a reaction to hypertriglyceridaemia and hepatic steatosis, hepatic <italic>miR-27b</italic> increases, which leads to an inhibition of <italic>de novo</italic> biosynthesis of TGs [<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>].</p><p>The PPAR&#x003b1; protein mainly occurs in the liver and is a regulator of multiple genes involved in fatty acid transport, catabolic processes and energy supply [<xref rid="B48-ijms-15-13494" ref-type="bibr">48</xref>]. <italic>miR-21</italic> and <italic>miR-27b</italic> both negatively regulate PPAR&#x003b1; [<xref rid="B48-ijms-15-13494" ref-type="bibr">48</xref>], and PPAR&#x003b1; protein levels in human liver-derived cell lines are decreased by over-expression of <italic>miR-21</italic> and <italic>miR-27b</italic> [<xref rid="B48-ijms-15-13494" ref-type="bibr">48</xref>]. Zheng <italic>et al.</italic> [<xref rid="B49-ijms-15-13494" ref-type="bibr">49</xref>] found PPAR&#x003b1; to be regulated by <italic>miR-10b</italic> in a human hepatocyte cell line. In this study, human hepatocyte L02 cells were cultured with an abundance of non-esterified fatty acids, as a non-alcoholic fatty liver disease (NAFLD) model. Upon treatment with these non-esterified fatty acids, <italic>miR-10b</italic> levels were up-regulated in hepatocytes [<xref rid="B49-ijms-15-13494" ref-type="bibr">49</xref>]. The PPAR&#x003b1; (<italic>PPARA</italic>) gene is a target of <italic>miR-10b</italic>, and thus, PPAR&#x003b1; protein levels are significantly decreased in the L02 cells. It is probable that <italic>miR-10b</italic> and its regulation of PPAR&#x003b1; is a condition occurring in certain liver diseases, such as NAFLD [<xref rid="B49-ijms-15-13494" ref-type="bibr">49</xref>].</p><p>miRNAs also play a considerable role in cholesterol metabolism [<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>]. First of all, <italic>miR-33a</italic> and <italic>miR-33b</italic> have been investigated with regards to cholesterol [<xref rid="B50-ijms-15-13494" ref-type="bibr">50</xref>,<xref rid="B51-ijms-15-13494" ref-type="bibr">51</xref>,<xref rid="B52-ijms-15-13494" ref-type="bibr">52</xref>,<xref rid="B53-ijms-15-13494" ref-type="bibr">53</xref>,<xref rid="B54-ijms-15-13494" ref-type="bibr">54</xref>,<xref rid="B55-ijms-15-13494" ref-type="bibr">55</xref>]. <italic>miR-33a</italic> is located within intron 16 of sterol-regulatory-element-binding protein 2 (<italic>SREBP2</italic>), which is a central transcription factor in lipid metabolism [<xref rid="B51-ijms-15-13494" ref-type="bibr">51</xref>,<xref rid="B52-ijms-15-13494" ref-type="bibr">52</xref>,<xref rid="B55-ijms-15-13494" ref-type="bibr">55</xref>]. When cholesterol is low, SREBP2 is released from the endoplasmic reticulum and enters the nucleus where it activates and increases cellular cholesterol synthesis, leading to increased low-density lipoprotein (LDL) cholesterol uptake [<xref rid="B56-ijms-15-13494" ref-type="bibr">56</xref>]. SREBP2 and <italic>miR-33a</italic> are activated consecutively, and <italic>miR-33a</italic> directly targets and diminishes ATP-binding cassette transporter A1 (<italic>ABCA1</italic>) mRNA levels, thus repressing cholesterol efflux from the cells. Since <italic>miR-33a</italic> and <italic>miR-33b</italic> are located in the introns of the <italic>SREBP</italic> genes, they are involved in controlling cholesterol and lipid metabolism. <italic>miR-33a/b</italic> also targets ATP-binding cassette transporter G1; cholesterol efflux (<italic>ABCG1</italic>), Niemann-Pick C1; cholesterol storage (<italic>NPC1</italic>), ATP-binding cassette transporter B11; bile secretion (<italic>ABCB11</italic>) and phospholipid transporting ATPase IC; bile acid secretion (<italic>ATP8B1</italic>) [<xref rid="B51-ijms-15-13494" ref-type="bibr">51</xref>,<xref rid="B52-ijms-15-13494" ref-type="bibr">52</xref>,<xref rid="B55-ijms-15-13494" ref-type="bibr">55</xref>,<xref rid="B57-ijms-15-13494" ref-type="bibr">57</xref>]. These genes are all involved in cholesterol metabolism. Furthermore, it was found that <italic>miR-33a/b</italic> play a central role in fatty acid &#x003b2;-oxidation, because they target carnitine <italic>O</italic>-octanyl transferase (<italic>CROT</italic>), carnitine palmitoyltransferase 1A (<italic>CPT1A</italic>) and hydroxyacyl-CoA dehydrogenase-3-ketoacyl-CoA thiolase-enoyl-CoA hydratase &#x003b2;-subunit (<italic>HADHB</italic>) [<xref rid="B53-ijms-15-13494" ref-type="bibr">53</xref>,<xref rid="B58-ijms-15-13494" ref-type="bibr">58</xref>]. In a study on non-human primates, the inhibition of <italic>miR-33a/b</italic> was associated with reduced VLDL (very low-density lipoprotein) secretion and reduced plasma TG levels [<xref rid="B59-ijms-15-13494" ref-type="bibr">59</xref>]. <italic>miR-122</italic> was also found to influence lipid metabolism, since anti-<italic>miR-122</italic> therapy reduced cholesterol levels in mice and primates significantly [<xref rid="B45-ijms-15-13494" ref-type="bibr">45</xref>,<xref rid="B60-ijms-15-13494" ref-type="bibr">60</xref>,<xref rid="B61-ijms-15-13494" ref-type="bibr">61</xref>]. Most likely, <italic>miR-122</italic> down-regulates genes playing a key-role in cholesterol metabolism, such as 3-hydroxy-3-methylglutaryl-CoA reductase (<italic>HMGCR</italic>) and 3-hydroxy-3-methylglutaryl-CoA synthase 1 (<italic>HMGCS1</italic>) [<xref rid="B62-ijms-15-13494" ref-type="bibr">62</xref>,<xref rid="B63-ijms-15-13494" ref-type="bibr">63</xref>,<xref rid="B64-ijms-15-13494" ref-type="bibr">64</xref>]. <italic>miR-122-</italic>deficient mice had a significantly reduced serum TG rate, suggesting that <italic>miR-122</italic> is involved in TG metabolism [<xref rid="B64-ijms-15-13494" ref-type="bibr">64</xref>].</p><p>Recently it was found that <italic>miR-144</italic> regulates the expression of <italic>ABCA1</italic> in macrophages and hepatocytes, and over-expression of <italic>miR-144</italic> in murine macrophages inhibits ABCA1 protein expression [<xref rid="B65-ijms-15-13494" ref-type="bibr">65</xref>]. It was demonstrated that over-expression of <italic>miR-144</italic> reduces, and inhibition of <italic>miR-144</italic> increases, circulating HDL levels in mice [<xref rid="B65-ijms-15-13494" ref-type="bibr">65</xref>]. Other miRNAs that play essential roles in lipid metabolism by targeting and repressing <italic>ABCA1</italic> in various cell types are <italic>miR-106</italic>, <italic>miR-26</italic> and <italic>miR-758</italic> [<xref rid="B66-ijms-15-13494" ref-type="bibr">66</xref>,<xref rid="B67-ijms-15-13494" ref-type="bibr">67</xref>,<xref rid="B68-ijms-15-13494" ref-type="bibr">68</xref>]. <italic>miR-1</italic>, <italic>miR-206</italic> and <italic>miR-613</italic> have been reported to repress lipogenesis by targeting liver X receptor alpha (LXR&#x003b1;) [<xref rid="B69-ijms-15-13494" ref-type="bibr">69</xref>,<xref rid="B70-ijms-15-13494" ref-type="bibr">70</xref>]. <italic>miR-146&#x003b1;</italic> has been shown to repress Toll-like receptor 4 (TLR4) signaling, and to inhibit oxidized LDL (oxLDL) cholesterol uptake in macrophages [<xref rid="B71-ijms-15-13494" ref-type="bibr">71</xref>].</p><p><italic>miR-155</italic>, a miRNA that is usually associated with inflammation, has been reported to repress lipid uptake in oxLDL-stimulated dendritic cells, because it targets and down-regulates the scavenger receptor, CD36, and the lectin-type oxidized LDL receptor 1 (LOX-1). oxLDL stimulation was found to up-regulate <italic>miR-155</italic>, together with <italic>miR-9</italic>, <italic>miR-146a</italic>, <italic>miR-125a-5p</italic> and <italic>miR-146-5p</italic>, in monocytes [<xref rid="B72-ijms-15-13494" ref-type="bibr">72</xref>]. Chen <italic>et al.</italic> [<xref rid="B72-ijms-15-13494" ref-type="bibr">72</xref>] found, that <italic>miR-125-5p</italic> was repressing lipid uptake by targeting oxysterol-binding protein-like 9 (ORP9). In another study it was shown that <italic>miR-155</italic> increased both lipid uptake and inflammation in oxLDL-stimulated macrophages [<xref rid="B73-ijms-15-13494" ref-type="bibr">73</xref>]. <italic>miR-125</italic>, <italic>miR-455-5p</italic>, <italic>miR-185</italic>, <italic>miR-96</italic> and <italic>miR-233</italic> have been reported to reduce HDL cholesterol uptake [<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>,<xref rid="B74-ijms-15-13494" ref-type="bibr">74</xref>,<xref rid="B75-ijms-15-13494" ref-type="bibr">75</xref>]. In a recent study, <italic>miR-217</italic> was found to influence the repression of ethanol-induced sirtuin 1 (<italic>SIRT1</italic>) and to promote ethanol-induced lipid accumulation and fatty acid synthesis [<xref rid="B76-ijms-15-13494" ref-type="bibr">76</xref>]. According to this study, <italic>miR-217</italic> plays a central role in fatty acid oxidation and in fatty acid synthesis [<xref rid="B76-ijms-15-13494" ref-type="bibr">76</xref>].</p><p>Single nucleotide polymorphisms have recently been identified within the miRNAs and in the miRNA target sites [<xref rid="B77-ijms-15-13494" ref-type="bibr">77</xref>,<xref rid="B78-ijms-15-13494" ref-type="bibr">78</xref>,<xref rid="B79-ijms-15-13494" ref-type="bibr">79</xref>,<xref rid="B80-ijms-15-13494" ref-type="bibr">80</xref>,<xref rid="B81-ijms-15-13494" ref-type="bibr">81</xref>]. For example, a gain-of-function variant in the lipoprotein lipase (<italic>LPL</italic>) gene apparently abolishes a <italic>miR-410</italic> target site [<xref rid="B82-ijms-15-13494" ref-type="bibr">82</xref>].</p><p>Summarizing these findings, it is obvious that a vast variety of miRNAs play a role in dyslipidaemia and related processes. Whether any of these miRNAs can be used as disease biomarkers or therapeutic targets remains to be investigated in detail. <xref ref-type="table" rid="ijms-15-13494-t001">Table 1</xref> summarizes the most notable data concerning miRNAs and their role in dyslipidaemia (<xref ref-type="table" rid="ijms-15-13494-t001">Table 1</xref>).</p><table-wrap id="ijms-15-13494-t001" position="float"><object-id pub-id-type="pii">ijms-15-13494-t001_Table 1</object-id><label>Table 1</label><caption><p>Micro RNAs and their involvement in dyslipidaemia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">miRNA</th><th align="center" valign="middle" rowspan="1" colspan="1">Target</th><th align="center" valign="middle" rowspan="1" colspan="1">Site</th><th align="center" valign="middle" rowspan="1" colspan="1">Effect</th><th align="center" valign="middle" rowspan="1" colspan="1">References</th><th align="center" valign="middle" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-27b</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Heparan sulfate <italic>N</italic>-deacetylase/<italic>N</italic>-sulfotransferase 1 (NDST1), angiopoietin-like 3 (ANGPTL3), peroxisome proliferator-activated receptor &#x003b3; (PPARG), glycerol-3-phosphate acyltransferase 1 (GPAM)</td><td align="center" valign="middle" rowspan="1" colspan="1">Murine liver tissue</td><td align="left" valign="middle" rowspan="1" colspan="1">As reaction to elevated plasma triglycerides (TGs) and liver steatosis, hepatic <italic>miR-27b</italic> was increased, and the ANGPTL3 and GPAM protein were repressed. As reaction to hypertriglyceridaemia and hepatic steatosis, hepatic <italic>miR-27b</italic> increases, leading to an inhibition of de novo biosynthesis of TGs.</td><td align="center" valign="middle" rowspan="1" colspan="1">Vickers 2013 [<xref rid="B47-ijms-15-13494" ref-type="bibr">47</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-21</italic>, <italic>miR-27b</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">PPAR&#x003b1; protein</td><td align="center" valign="middle" rowspan="1" colspan="1">Human liver-derived cell lines</td><td align="left" valign="middle" rowspan="1" colspan="1">PPAR&#x003b1; protein levels in human liver-derived cell lines were decreased by over-expression of <italic>miR-21</italic> and <italic>miR-27b</italic>.</td><td align="center" valign="middle" rowspan="1" colspan="1">Kida 2011 [<xref rid="B48-ijms-15-13494" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-10b</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">PPAR&#x003b1; protein</td><td align="center" valign="middle" rowspan="1" colspan="1">Human hepatocyte cell line</td><td align="left" valign="middle" rowspan="1" colspan="1">Human hepatocyte L02 cells were cultured with an abundance of non-esterified fatty acids, as a non-alcoholic fatty liver disease (NAFLD) model. Upon this treatment <italic>miR-10b</italic> levels were up-regulated. PPAR&#x003b1; (PPARA) was decreased at protein level in the L02 cells.</td><td align="center" valign="middle" rowspan="1" colspan="1">Zheng 2010 [<xref rid="B49-ijms-15-13494" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-33a</italic>, <italic>miR-33b</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">ATP-binding cassette transporter G1; cholesterol efflux (ABCG1), Niemann-Pick C1; cholesterol storage (NPC1), ATP-binding cassette transporter B11; bile secretion (ABCB11), phospholipid transporting ATPase IC; bile acid secretion (ATP8B1)</td><td align="center" valign="middle" rowspan="1" colspan="1">Liver (human)</td><td align="left" valign="middle" rowspan="1" colspan="1">Regulation of cholesterol homeostasis, regulation of cholesterol transport. Expression of <italic>miR-33</italic> inhibits cholesterol export and fatty acid oxidation.</td><td align="center" valign="middle" rowspan="1" colspan="1">Rayner 2010 [<xref rid="B51-ijms-15-13494" ref-type="bibr">51</xref>], Marquart 2010 [<xref rid="B52-ijms-15-13494" ref-type="bibr">52</xref>], Najafi-Shoushtari 2010 [<xref rid="B55-ijms-15-13494" ref-type="bibr">55</xref>], Allen 2012 [<xref rid="B57-ijms-15-13494" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-33a</italic>, <italic>miR-33b</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Carnitine <italic>O</italic>-octanyl transferase (CROT), carnitine palmitoyltransferase 1A (CPT1A), hydroxyacyl-CoA dehydrogenase-3-ketoacyl-CoA thiolase-enoyl-CoA hydratase &#x003b2;-subunit (HADHB)</td><td align="center" valign="middle" rowspan="1" colspan="1">Liver (non-human primates)</td><td align="left" valign="middle" rowspan="1" colspan="1">Regulation of fatty acid &#x003b2;-oxidation. Inhibition of <italic>miR-33a/b</italic> was associated with reduced VLDL (very-low-density lipoprotein) secretion and reduced plasma TG levels.</td><td align="center" valign="middle" rowspan="1" colspan="1">Gerin 2010 [<xref rid="B53-ijms-15-13494" ref-type="bibr">53</xref>], Davalos 2011 [<xref rid="B58-ijms-15-13494" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-122</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1)</td><td align="center" valign="middle" rowspan="1" colspan="1">Liver (mice, primates)</td><td align="left" valign="middle" rowspan="1" colspan="1">Anti-miR-122 therapy reduced cholesterol levels in mice and primates. miR-122 down-regulates genes playing a key-role in cholesterol metabolism such as HMGCR and HMGCS1 miR-122-deficient mice had a significantly reduced serum TG rate.</td><td colspan="2" align="center" valign="middle" rowspan="1">Esau 2006 [45], Elmen 2008 [<xref rid="B60-ijms-15-13494" ref-type="bibr">60</xref>,<xref rid="B61-ijms-15-13494" ref-type="bibr">61</xref>], Krutzfeld 2005 [<xref rid="B62-ijms-15-13494" ref-type="bibr">62</xref>], Hsa 2012 [<xref rid="B63-ijms-15-13494" ref-type="bibr">63</xref>], Tsai 2012 [<xref rid="B64-ijms-15-13494" ref-type="bibr">64</xref>]</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-144</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">ATP-binding cassette transporter A1 (ABCA1)</td><td align="center" valign="middle" rowspan="1" colspan="1">Liver (mice)</td><td align="left" valign="middle" rowspan="1" colspan="1">miR-144 regulates the expression of ABCA1 in macrophages and hepatocytes. Over-expression of miR-144 in murine macrophages inhibits ABCA1 protein expression. Over-expression of miR-144 reduces, and inhibition of miR-144 increases circulating HDL levels in mice.</td><td colspan="2" align="center" valign="middle" rowspan="1">Ramirez 2013 [<xref rid="B65-ijms-15-13494" ref-type="bibr">65</xref>]</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-1</italic>, <italic>miR-206</italic>, <italic>miR-613</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Liver X receptor alpha (LXR&#x003b1;)</td><td align="center" valign="middle" rowspan="1" colspan="1">Human hepatocytes</td><td align="left" valign="middle" rowspan="1" colspan="1">Repress lipogenesis by targeting liver X receptor alpha (LXR&#x003b1;).</td><td colspan="2" align="center" valign="middle" rowspan="1">Zhong 2013 [<xref rid="B69-ijms-15-13494" ref-type="bibr">69</xref>,<xref rid="B70-ijms-15-13494" ref-type="bibr">70</xref>]</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-146&#x003b1;</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Toll-like receptor 4 (TLR4)</td><td align="center" valign="middle" rowspan="1" colspan="1">Human macrophages</td><td align="left" valign="middle" rowspan="1" colspan="1">miR-146&#x003b1; represses Toll-like receptor 4 (TLR4) signaling, and inhibits oxidized LDL (oxLDL) cholesterol uptake in macrophages.</td><td colspan="2" align="center" valign="middle" rowspan="1">Yang 2011 [<xref rid="B71-ijms-15-13494" ref-type="bibr">71</xref>]</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-155</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Scavenger receptor, CD36; lectintype oxidized LDL receptor 1 (LOX-1)</td><td align="center" valign="middle" rowspan="1" colspan="1">Human dendritic cells</td><td align="left" valign="middle" rowspan="1" colspan="1">miR-155 represses lipid uptake in oxLDL-stimulated dendritic cells.</td><td colspan="2" align="center" valign="middle" rowspan="1">Chen 2009 [<xref rid="B72-ijms-15-13494" ref-type="bibr">72</xref>]</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-125-5p</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Oxysterol-binding protein-like 9 (ORP6)</td><td align="center" valign="middle" rowspan="1" colspan="1">Human macrophages</td><td align="left" valign="middle" rowspan="1" colspan="1">miR-125-5p represses lipid uptake in macrophages.</td><td colspan="2" align="center" valign="middle" rowspan="1">Chen 2009 [<xref rid="B72-ijms-15-13494" ref-type="bibr">72</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>2.2. HDL (High-Density Lipoprotein) Cholesterol and Extracellular miRNAs</title><p>Extracellular miRNAs are detectable in the blood plasma and are protected from degradation, because of packaging in microvesicles, exosomes and apoptotic bodies, or because of their linkage to proteins [<xref rid="B83-ijms-15-13494" ref-type="bibr">83</xref>]. HDL particles were found to transport endogenous miRNAs, and deliver them to recipient cells [<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>]. In individuals suffering from familial hypercholesterolaemia (FH), HDL-miRNA profiles significantly differ from healthy controls, indicating that the function of miRNAs is altered when carried by HDL [<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>]. FH-HDL was found to have a greater concentration of miRNAs that are most abundantly found in normal HDL, and FH-HDL also contained more individual miRNAs compared to normal HDL. In a study where normal HDL was enriched with the most abundant FH-HDL miRNA, <italic>hsa-miR-233</italic>, it was shown that the recipient cells had increased intracellular <italic>miR-223</italic> levels and that <italic>miR-233</italic> target genes were reduced, such as member B of the Ras homolog gene family (<italic>RhoB</italic>), and Ephrin A1 (<italic>EFNA1</italic>). When FH-HDL-miRNAs were introduced to hepatocytes in cell culture, a significant loss of conserved mRNA targets compared with normal HDL-miRNAs was observed. The down-regulated genes were mostly (79 out of 91) potential targets of miRNAs that were abundantly present in FH-HDL [<xref rid="B41-ijms-15-13494" ref-type="bibr">41</xref>]. It was recently discovered that the properties of HDL cholesterol, e.g., anti-oxidative, anti-inflammatory and anti-thrombotic, can be very heterogeneous and that HDL cholesterol function may be altered in individuals suffering from cardiovascular disease or diabetes [<xref rid="B84-ijms-15-13494" ref-type="bibr">84</xref>]. Thus, it is possible that HDL-carried miRNAs contribute to this heterogeneity of HDL function, altering the effect of HDL on endothelial cells and macrophages.</p></sec><sec><title>2.3. Vascular Inflammation</title><p>For atherogenesis, vascular inflammation is the first event to take place, leading to the development of an atherosclerotic lesion. In this process, proinflammatory cytokines, like tumor necrosis factor-alpha (TNF-&#x003b1;), enhance the expression of adhesion molecules in endothelial cells and thus lead to the recruiting of inflammatory cells to the inflammation site [<xref rid="B85-ijms-15-13494" ref-type="bibr">85</xref>,<xref rid="B86-ijms-15-13494" ref-type="bibr">86</xref>]. The TNF-&#x003b1;-mediated activation of endothelial cells has been demonstrated to decrease <italic>miR-181b</italic> expression [<xref rid="B68-ijms-15-13494" ref-type="bibr">68</xref>]. It was evident that both <italic>in vitro</italic> and <italic>in vivo</italic> over-expression of <italic>miR-181b</italic> blocks the expression of adhesion molecules, like vascular adhesion molecule 1 (VCAM-1). Interestingly, <italic>miR-181b</italic> leads to a decrease in endothelial cell activation and leukocyte recruiting in lipopolysaccharide-induced lung injury, when administered systemically. Furthermore, <italic>miR-181b</italic> has been shown to diminish the nuclear translocation of nuclear factor kappa B (NF-&#x003ba;B), targeting importin-&#x003b1;3. It is therefore likely that the inhibitory effect of <italic>miR-181b</italic> on the expression of adhesion molecules results from the inhibition of NF-&#x003ba;B nuclear translocation [<xref rid="B68-ijms-15-13494" ref-type="bibr">68</xref>].</p><p>According to Harris <italic>et al.</italic> [<xref rid="B87-ijms-15-13494" ref-type="bibr">87</xref>], <italic>miR-126</italic> and <italic>miR-195</italic> are also involved in vascular inflammation. In fact, <italic>miR-126</italic> is abundantly expressed in endothelial cells and oppresses their VCAM-1 expression. <italic>miR-126</italic> also decreases leukocyte binding to TNF-&#x003b1;-activated endothelial cells [<xref rid="B87-ijms-15-13494" ref-type="bibr">87</xref>].</p><p>In a study by Hu <italic>et al.</italic> [<xref rid="B88-ijms-15-13494" ref-type="bibr">88</xref>], it was demonstrated that down-regulation of <italic>miR-144-3p</italic>, a miRNA targeting <italic>ABCA1</italic> which mediates reverse cholesterol transport, resulted in plaque formation. In this study, <italic>ABCA1</italic> was identified as a potential target of <italic>miR-144-3p</italic>, since <italic>ABCA1</italic> was down-regulated after transfection of cells with <italic>miR-144-3p</italic> mimics. The <italic>miR-144-3p</italic> mimics enhanced the expression of inflammatory factors, namely interleukin 1&#x003b2;, interleukin 6 and TNF-&#x003b1;, and blocked cholesterol efflux in a THP-1 macrophage-derived foam cell line, decreased HDL cholesterol circulation and inhibited reverse cholesterol transport <italic>in vivo</italic> [<xref rid="B88-ijms-15-13494" ref-type="bibr">88</xref>]. These events resulted in accelerated pathological progression of atherosclerotic lesions in <italic>apoE<sup>&#x02212;/&#x02212;</sup></italic> mice. The authors concluded <italic>miR-144-3p</italic> as being a key regulator of cholesterol homeostasis, mediating inflammatory reactions in atherogenesis. It is furthermore possible that <italic>miR-144-3p</italic> is a therapeutic target for the treatment of atherosclerosis [<xref rid="B88-ijms-15-13494" ref-type="bibr">88</xref>].</p></sec><sec><title>2.4. Oxidative Stress</title><p>Reactive oxygen species (ROS) is a term that includes reactive and partially reduced oxygen metabolites, for example superoxide anion (O<sub>2</sub>&#x02212;), hydroxyl radicals or hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) [<xref rid="B89-ijms-15-13494" ref-type="bibr">89</xref>]. ROS can cause damage to DNA, proteins and fatty acids, and therefore a redox imbalance resulting from excessive ROS production or insufficient scavenging may lead to cardiovascular disease, for example hypertension, hypercholesterolaemia and atherosclerosis [<xref rid="B90-ijms-15-13494" ref-type="bibr">90</xref>,<xref rid="B91-ijms-15-13494" ref-type="bibr">91</xref>,<xref rid="B92-ijms-15-13494" ref-type="bibr">92</xref>].</p><p>Different miRNAs have been identified to play a role in oxidative stress and consecutive endothelial and vascular dysfunction [<xref rid="B93-ijms-15-13494" ref-type="bibr">93</xref>]. Several miRNAs are known to be associated with cardiovascular disease, diabetes and obesity due to redox imbalance [<xref rid="B93-ijms-15-13494" ref-type="bibr">93</xref>].</p><p>For example, up-regulation of <italic>miR-200c</italic>, <italic>miR-141</italic>, <italic>miR-200a</italic>, <italic>miR-200b</italic> and <italic>miR-429</italic>, targeting the zinc finger E-box binding homeobox 1 (<italic>ZEB1</italic>) gene, is associated with apoptosis and senescence caused by H<sub>2</sub>O<sub>2</sub> in the endothelium [<xref rid="B71-ijms-15-13494" ref-type="bibr">71</xref>]. <italic>miR-200c</italic> and <italic>miR-141</italic> up-regulation is associated with obesity, as up-regulation of these miRNAs was identified in the heart of obese rats [<xref rid="B94-ijms-15-13494" ref-type="bibr">94</xref>]. Another association with obesity in rats was found for up-regulation of <italic>miR-155</italic>, <italic>miR-183</italic> and <italic>miR-872</italic> [<xref rid="B94-ijms-15-13494" ref-type="bibr">94</xref>]. These miRNAs target Heme Oxygenase (Decycling) 1 (<italic>HO-1</italic>), and their up-regulation leads to inflammation, oxidative damage and apoptosis [<xref rid="B94-ijms-15-13494" ref-type="bibr">94</xref>]. <italic>miR-200c</italic> and <italic>miR-141</italic> target ribosomal protein S6 kinase, 70 kDa, polypeptide 1 (<italic>S6K1</italic>) which encodes a protein responding to mTOR (mammalian target of rapamycin)-signaling to promote protein synthesis, cell growth, and cell proliferation [<xref rid="B95-ijms-15-13494" ref-type="bibr">95</xref>]. <italic>miR-217</italic> was identified to be up-regulated in human atherosclerotic plaques, and targets the <italic>SIRT1</italic> gene, which leads to endothelial dysfunction [<xref rid="B96-ijms-15-13494" ref-type="bibr">96</xref>]. Up-regulation of <italic>miR-34</italic>, also targeting <italic>SIRT1</italic>, was found to be associated with myocardial infarction [<xref rid="B97-ijms-15-13494" ref-type="bibr">97</xref>].</p></sec><sec><title>2.5. lncRNAs, Atherosclerosis, Insulin Resistance and Adipogenesis</title><p>The chromosome 9p21 locus is the strongest genetic risk factor for atherosclerosis, although this gene locus is not associated with frequent cardiovascular disease risk factors, such as dyslipidaemia and hypertension [<xref rid="B98-ijms-15-13494" ref-type="bibr">98</xref>,<xref rid="B99-ijms-15-13494" ref-type="bibr">99</xref>,<xref rid="B100-ijms-15-13494" ref-type="bibr">100</xref>,<xref rid="B101-ijms-15-13494" ref-type="bibr">101</xref>]. Within the risk region, in the locus of the tumor suppressor protein INK4, lies the antisense lncRNA (<italic>ANRIL</italic>) [<xref rid="B102-ijms-15-13494" ref-type="bibr">102</xref>,<xref rid="B103-ijms-15-13494" ref-type="bibr">103</xref>]. A clear association between <italic>ANRIL</italic> with the chromosome 9p21 genotype has been found in several studies [<xref rid="B102-ijms-15-13494" ref-type="bibr">102</xref>,<xref rid="B103-ijms-15-13494" ref-type="bibr">103</xref>,<xref rid="B104-ijms-15-13494" ref-type="bibr">104</xref>,<xref rid="B105-ijms-15-13494" ref-type="bibr">105</xref>,<xref rid="B106-ijms-15-13494" ref-type="bibr">106</xref>,<xref rid="B107-ijms-15-13494" ref-type="bibr">107</xref>]. It was also demonstrated that <italic>ANRIL</italic> expression positively correlates with atherosclerosis severity [<xref rid="B108-ijms-15-13494" ref-type="bibr">108</xref>]. <italic>ANRIL</italic> regulates target-genes, leading to increased cell proliferation, increased cell adhesion and decreased apoptosis, which are known mechanisms of atherogenesis [<xref rid="B108-ijms-15-13494" ref-type="bibr">108</xref>]. In a study by Holdt <italic>et al.</italic> [<xref rid="B108-ijms-15-13494" ref-type="bibr">108</xref>], <italic>ANRIL-</italic>regulated networks were confirmed in 2280 individuals with and without coronary artery disease, and were functionally validated. It was shown that <italic>ANRIL</italic> isoforms, up-regulated in patients carrying the chromosome 9p21 atherosclerosis risk haplotype, modulate gene networks and lead to pro-atherogenic cellular properties, making them proliferate and forming cell contacts.</p><p>Insulin resistance constitutes a key step in the development of metabolic diseases. It was observed that insulin and insulin-like growth factor (IGF) 1 signaling also trigger distinct changes in lncRNA expression, as it was demonstrated for the lncRNA <italic>CRNDE</italic> [<xref rid="B109-ijms-15-13494" ref-type="bibr">109</xref>]. Thus, lncRNAs may be involved in the metabolic effects of insulin resistance. The role of the lncRNA <italic>H19</italic> in pancreatic islet development and function was investigated by Ding <italic>et al.</italic>, in 2012 [<xref rid="B110-ijms-15-13494" ref-type="bibr">110</xref>]. In this study <italic>H19</italic> was found to be involved in the intergenerational transmission of diabetes mellitus (gestational diabetes mellitus) and in the diabetes-associated impairment of islet structure and function. Intrauterine hyperglycaemia has been suggested to be a determinative factor for diabetes in adulthood [<xref rid="B111-ijms-15-13494" ref-type="bibr">111</xref>,<xref rid="B112-ijms-15-13494" ref-type="bibr">112</xref>]. Thus, further investigation of the role of ncRNAs in pancreatic islet cell function might contribute to a better understanding of why certain individuals carry a higher risk for diabetes compared to others.</p><p>Global lncRNA screening approaches systematically evaluated the lncRNA transcriptome in human pancreatic beta cells, and thereby &#x0003e;1000 lncRNAs were reported [<xref rid="B113-ijms-15-13494" ref-type="bibr">113</xref>]. By using RNA sequencing data of 16 non-pancreatic tissues, it was demonstrated that the pattern of pancreatic lncRNAs was significantly more specific for islet cells (40%&#x02013;55%) than the pattern of protein encoding genes (9.4%) [<xref rid="B113-ijms-15-13494" ref-type="bibr">113</xref>]. Up-regulation of islet-specific lncRNAs during glucose stimulation and their dysregulation in patients suffering from type 2 diabetes mellitus pointed to a pathophysiological role of lncRNAs in the integrity of pancreatic tissue [<xref rid="B113-ijms-15-13494" ref-type="bibr">113</xref>]. It was found that &#x0003e;1000 lncRNAs of the human beta cell ncRNA transcriptome were expressed in an islet-specific fashion involving islet-specific splicing events and promoter utilization [<xref rid="B114-ijms-15-13494" ref-type="bibr">114</xref>]. It remains to be elucidated exactly how lncRNAs mediate beta cell differentiation and function.</p><p>Accumulation of excess lipids in white adipose tissue, leading to low-grade inflammation, has been linked to the development of insulin resistance in obese individuals [<xref rid="B115-ijms-15-13494" ref-type="bibr">115</xref>,<xref rid="B116-ijms-15-13494" ref-type="bibr">116</xref>,<xref rid="B117-ijms-15-13494" ref-type="bibr">117</xref>]. lncRNAs are involved in the differentiation of adipose tissue, as for example the lncRNA <italic>SRA</italic>, which is required for full transactivation of the proadipogenic transcription factor Peroxisome proliferator-associated receptor gamma (Pparg) [<xref rid="B118-ijms-15-13494" ref-type="bibr">118</xref>]. Furthermore, RNAi-mediated loss-of-function of <italic>SRA</italic> interferes with <italic>in vitro</italic> differentiation of 3T3-L1 preadipocytes [<xref rid="B118-ijms-15-13494" ref-type="bibr">118</xref>].</p><p>In a study by Sun and colleagues the signatures and specific regulations of 175 lncRNAs during adipogenesis were reported, of which a significant number was enriched in the adipose tissue [<xref rid="B119-ijms-15-13494" ref-type="bibr">119</xref>]. In this study, certain lncRNAs that were specifically relevant for adipogenesis were depleted <italic>in vitro</italic> using siRNAs. Distinct lncRNAs were found to be specifically up-regulated during adipogenesis and were induced by the proadipogenic transcription factors <italic>Cebpa</italic> and <italic>Pparg.</italic> These lncRNAs were required for complete maturation of adipocyte progenitor cells. Thus, there is evidence for a crucial role of lncRNAs in the control of adipogenesis and fat cell metabolism [<xref rid="B119-ijms-15-13494" ref-type="bibr">119</xref>].</p></sec></sec><sec><title>3. Discussion</title><p>Evidently, a vast variety of non-coding RNAs, mostly miRNAs, play a role in dyslipidaemia and atherogenesis. These non-coding RNAs represent potential therapeutic targets for the treatment of various diseases that are associated with a dysfunctional lipid metabolism. However, the post-transcriptional regulation of genes by these non-coding RNAs is not completely clarified, and the exact mechanisms by which this gene-regulation takes place remain to be elucidated.</p><p>Recently it has been revealed that miRNAs are present in the blood plasma, rendering them probably useful as disease biomarkers [<xref rid="B27-ijms-15-13494" ref-type="bibr">27</xref>]. Since miRNAs are dysregulated in many diseases, the establishment of circulating miRNAs as biomarkers may be possible for any of these. However, the specificity of a given miRNA as biomarker for a certain disease remains to be investigated, because a miRNA may be involved in many different pathways, and false-positive results have to be avoided.</p><sec><title>miRNAs as Therapeutic Targets</title><p>miRNAs can be regulated by administration of miRNA targeting substances, as it has recently been demonstrated in cancer. It was shown in non-human primates that the administration of anti-miRNA oligonucleotides reduces <italic>miR-122</italic> activity in the liver [<xref rid="B60-ijms-15-13494" ref-type="bibr">60</xref>]. Suppression of oncogenic <italic>miR-221</italic> by antagonistic miRNAs resulted in prolonged survival and reduction of tumor number and size in a liver-cancer mouse model [<xref rid="B120-ijms-15-13494" ref-type="bibr">120</xref>]. Moreover, it was demonstrated that modulating miRNAs can make cancer cells more sensitive to chemotherapeutics [<xref rid="B121-ijms-15-13494" ref-type="bibr">121</xref>,<xref rid="B122-ijms-15-13494" ref-type="bibr">122</xref>].</p><p><italic>miR-24</italic>, a miRNA that is involved in human carcinogenesis, was demonstrated to be significantly down-regulated in gastric cancer tissue [<xref rid="B123-ijms-15-13494" ref-type="bibr">123</xref>]. As retrovirus-mediated gastric cancer cells expressing <italic>miR-24</italic> (SGC-7901/RV-<italic>miR-24</italic>) were injected into nude mice, tumor formation was found to occur much more slowly, compared to controls. Cell proliferation, migration and invasion, cell cycle arrest of tumor cells in G0/G1 phase and increased apoptosis were observed [<xref rid="B123-ijms-15-13494" ref-type="bibr">123</xref>]. Thus, <italic>miR-24</italic> functions as a tumor suppressor in gastric cancer cells, and is a potential therapeutic target in the treatment of gastric cancer [<xref rid="B123-ijms-15-13494" ref-type="bibr">123</xref>].</p><p>The ability to regulate miRNAs opens new options also for the treatment of dyslipidaemia, for example by the delivery of miRNA mimics to enhance miRNA function, or of anti-miRNAs to inhibit miRNA function [<xref rid="B124-ijms-15-13494" ref-type="bibr">124</xref>]. The miRNA mimic technology is an approach whereby gene silencing is achieved [<xref rid="B125-ijms-15-13494" ref-type="bibr">125</xref>]. Non-natural double-stranded miRNA-like RNA fragments are designed in a way that the 5'-end bears a partially complementary motif to a certain sequence in the 3'UTR (untranslated region) that is unique to the target gene. This RNA fragment is then introduced into cells and mimics an endogenous miRNA. It specifically binds to the target gene, which leads to posttranscriptional repression and inhibition of translation of the selected gene target [<xref rid="B125-ijms-15-13494" ref-type="bibr">125</xref>]. The advantage, in comparison to endogenous miRNAs, is the specificity for only one gene [<xref rid="B125-ijms-15-13494" ref-type="bibr">125</xref>].</p><p>Three different types of chemical modifications have been used to modify miRNA function <italic>in vivo</italic> [<xref rid="B126-ijms-15-13494" ref-type="bibr">126</xref>]. Firstly, anti-miRNAs can be linked to cholesterol (antago-miRNA) to facilitate cellular uptake. Secondly, oligonucleotides with locked nucleotides acid (anti-miRNAs) or, thirdly, 2'-<italic>O</italic>-methoxyethyl phosphorothioate modifications may be used [<xref rid="B126-ijms-15-13494" ref-type="bibr">126</xref>]. Anti-miRNAs are an approach for miRNA loss-of-function studies, in which chemically modified antisense oligonucleotides are used, which sequester the mature miRNA in competition with cellular target mRNAs. This leads to an inhibition of function of the miRNA, resulting in a de-repression of its targets [<xref rid="B127-ijms-15-13494" ref-type="bibr">127</xref>].</p><p><italic>miR-122</italic> was antagonized in mouse liver using these three classes of anti-miRNAs in three independent studies, and revealed <italic>miR-122</italic> antagonism to reduce plasma cholesterol levels in cardiovascular diseases, as for example cardiac hypertrophy, heart failure, arrhythmia and atherosclerosis [<xref rid="B45-ijms-15-13494" ref-type="bibr">45</xref>,<xref rid="B61-ijms-15-13494" ref-type="bibr">61</xref>,<xref rid="B62-ijms-15-13494" ref-type="bibr">62</xref>]. Thus, all of these approaches can be used for therapeutic purposes [<xref rid="B126-ijms-15-13494" ref-type="bibr">126</xref>]. For miRNAs that are pathologically down-regulated, miRNA re-expression strategies must be used, whereas anti-miRNA strategies are used to suppress up-regulated miRNAs.</p><p>Rayner and colleagues conducted a study where an anti-miRNA oligonucleotide, targeting both <italic>miR-33a</italic> and <italic>miR-33b</italic>, was systemically delivered to African green monkeys. As a result, hepatic ABCA1 expression was increased, and plasma HDL cholesterol levels were sustainably increased over 12 weeks [<xref rid="B59-ijms-15-13494" ref-type="bibr">59</xref>]. The expression of several <italic>miR-33b</italic> target genes, all involved in fatty acid oxidation, was also increased, namely <italic>CROT</italic>, <italic>CPT1A</italic>, <italic>HADHB</italic> and <italic>PRKAA1</italic>. The expression levels of genes involved in fatty acid synthesis (<italic>SREBF1</italic>, <italic>FASN</italic>, <italic>ACYL</italic> and <italic>ACACA</italic>) were decreased, resulting in distinct suppression of plasma VLDL-associated TGs [<xref rid="B59-ijms-15-13494" ref-type="bibr">59</xref>]. These findings suggest <italic>miR-33a</italic> and <italic>miR-33b</italic> inhibition to be potential therapeutic strategies for the prevention and treatment of atherosclerosis, raising HDL cholesterol and lowering VLDL and TG levels [<xref rid="B59-ijms-15-13494" ref-type="bibr">59</xref>].</p><p>miRNA inhibitors that can be expressed in cells, so-called miRNA sponges, have been developed as an alternative to chemically modified antisense oligonucleotides [<xref rid="B128-ijms-15-13494" ref-type="bibr">128</xref>]. These miRNA sponges are RNAs produced from transgenes, working as competitive miRNA-inhibitors. miRNA sponges are transcripts expressed by strong promoters, which contain multiple binding sites for a given miRNA of interest [<xref rid="B128-ijms-15-13494" ref-type="bibr">128</xref>]. Vectors encoding these miRNA sponges can be transfected into cultured cells, and consecutively certain miRNA targets are de-repressed by inhibition of the targeting miRNA [<xref rid="B128-ijms-15-13494" ref-type="bibr">128</xref>].</p></sec></sec><sec><title>4. Conclusions</title><p>Vascular diseases and dyslipidaemia are complex and multifactorial diseases, in which many genes are involved.</p><p>When considering miRNAs as potential disease biomarkers or therapeutic targets, one must take into account the fact that miRNAs regulate several genes at once. With the manipulation of a given miRNA, the expression and function of many genes may be altered, and thus, harmful and unexpected side effects may occur. When, for therapeutic purposes, a certain gene that is known to be regulated by a certain miRNA, is targeted, it must be kept in mind that a gene is usually regulated not only by one, but by several miRNAs.</p><p>Further studies on miRNAs and lncRNAs are necessary to clarify their <italic>in vivo</italic> effect as biomarkers and/or therapeutic targets, and to outline their clinical relevance.</p></sec></body><back><notes><title>Conflicts of Interest</title><p>The authors of this manuscript declare that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.</p></notes><ref-list><title>References</title><ref id="B1-ijms-15-13494"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Tran</surname><given-names>E.J.</given-names></name></person-group>
<article-title>Unexpected functions of lncRNAs in gene regulation</article-title>
<source>Commun. Integr. Biol.</source>
<year>2013</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.4161/cib.27610</pub-id>
</element-citation></ref><ref id="B2-ijms-15-13494"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ulitsky</surname><given-names>I.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>LincRNAs: Genomics, evolution, and mechanisms</article-title>
<source>Cell</source>
<year>2013</year>
<volume>154</volume>
<fpage>26</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.06.020</pub-id>
<pub-id pub-id-type="pmid">23827673</pub-id></element-citation></ref><ref id="B3-ijms-15-13494"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Djebali</surname><given-names>S.</given-names></name><name><surname>Davis</surname><given-names>C.A.</given-names></name><name><surname>Merkel</surname><given-names>A.</given-names></name><name><surname>Dobin</surname><given-names>A.</given-names></name><name><surname>Lassmann</surname><given-names>T.</given-names></name><name><surname>Mortazavi</surname><given-names>A.</given-names></name><name><surname>Tanzer</surname><given-names>A.</given-names></name><name><surname>Lagarde</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Schlesinger</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Landscape of transcription in human cells</article-title>
<source>Nature</source>
<year>2012</year>
<volume>489</volume>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1038/nature11233</pub-id>
<pub-id pub-id-type="pmid">22955620</pub-id></element-citation></ref><ref id="B4-ijms-15-13494"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Novikova</surname><given-names>I.V.</given-names></name><name><surname>Hennelly</surname><given-names>S.P.</given-names></name><name><surname>Tung</surname><given-names>C.S.</given-names></name><name><surname>Sanbonmatsu</surname><given-names>K.Y.</given-names></name></person-group>
<article-title>Rise of the RNA machines: Exploring the structure of long non-coding RNAs</article-title>
<source>J. Mol. Biol.</source>
<year>2013</year>
<volume>425</volume>
<fpage>3731</fpage>
<lpage>3746</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmb.2013.02.030</pub-id>
<pub-id pub-id-type="pmid">23467124</pub-id></element-citation></ref><ref id="B5-ijms-15-13494"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kornfeld</surname><given-names>J.W.</given-names></name><name><surname>Bruning</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Regulation of metabolism by long, non-coding RNAs</article-title>
<source>Front. Genet.</source>
<year>2014</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.3389/fgene.2014.00057</pub-id>
</element-citation></ref><ref id="B6-ijms-15-13494"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Penny</surname><given-names>G.D.</given-names></name><name><surname>Kay</surname><given-names>G.F.</given-names></name><name><surname>Sheardown</surname><given-names>S.A.</given-names></name><name><surname>Rastan</surname><given-names>S.</given-names></name><name><surname>Brockdorff</surname><given-names>N.</given-names></name></person-group>
<article-title>Requirement for Xist in X chromosome inactivation</article-title>
<source>Nature</source>
<year>1996</year>
<volume>379</volume>
<fpage>131</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1038/379131a0</pub-id>
<pub-id pub-id-type="pmid">8538762</pub-id></element-citation></ref><ref id="B7-ijms-15-13494"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dinger</surname><given-names>M.E.</given-names></name><name><surname>Pang</surname><given-names>K.C.</given-names></name><name><surname>Mercer</surname><given-names>T.R.</given-names></name><name><surname>Mattick</surname><given-names>J.S.</given-names></name></person-group>
<article-title>Differentiating protein-coding and noncoding RNA: Challenges and ambiguities</article-title>
<source>PLoS Comput. Biol.</source>
<year>2008</year>
<volume>4</volume>
<fpage>e1000176</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1000176</pub-id>
<pub-id pub-id-type="pmid">19043537</pub-id></element-citation></ref><ref id="B8-ijms-15-13494"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ernst</surname><given-names>C.</given-names></name><name><surname>Morton</surname><given-names>C.C.</given-names></name></person-group>
<article-title>Identification and function of long non-coding RNA</article-title>
<source>Front. Cell. Neurosci.</source>
<year>2013</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00168</pub-id>
</element-citation></ref><ref id="B9-ijms-15-13494"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y.F.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.Q.</given-names></name><name><surname>Song</surname><given-names>L.J.</given-names></name><name><surname>Liang</surname><given-names>H.X.</given-names></name><name><surname>Li</surname><given-names>Z.Q.</given-names></name><name><surname>Tao</surname><given-names>F.B.</given-names></name></person-group>
<article-title>Role of long non-coding RNAs in gene regulation and oncogenesis</article-title>
<source>Chin. Med. J.</source>
<year>2011</year>
<volume>124</volume>
<fpage>2378</fpage>
<lpage>2383</lpage>
<pub-id pub-id-type="pmid">21933572</pub-id></element-citation></ref><ref id="B10-ijms-15-13494"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hangauer</surname><given-names>M.J.</given-names></name><name><surname>Vaughn</surname><given-names>I.W.</given-names></name><name><surname>McManus</surname><given-names>M.T.</given-names></name></person-group>
<article-title>Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs</article-title>
<source>PLoS Genet.</source>
<year>2013</year>
<volume>9</volume>
<fpage>e1003569</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003569</pub-id>
<pub-id pub-id-type="pmid">23818866</pub-id></element-citation></ref><ref id="B11-ijms-15-13494"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derrien</surname><given-names>T.</given-names></name><name><surname>Johnson</surname><given-names>R.</given-names></name><name><surname>Bussotti</surname><given-names>G.</given-names></name><name><surname>Tanzer</surname><given-names>A.</given-names></name><name><surname>Djebali</surname><given-names>S.</given-names></name><name><surname>Tilgner</surname><given-names>H.</given-names></name><name><surname>Guernec</surname><given-names>G.</given-names></name><name><surname>Martin</surname><given-names>D.</given-names></name><name><surname>Merkel</surname><given-names>A.</given-names></name><name><surname>Knowles</surname><given-names>D.G.</given-names></name><etal/></person-group>
<article-title>The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression</article-title>
<source>Genome Res.</source>
<year>2012</year>
<volume>22</volume>
<fpage>1775</fpage>
<lpage>1789</lpage>
<pub-id pub-id-type="doi">10.1101/gr.132159.111</pub-id>
<pub-id pub-id-type="pmid">22955988</pub-id></element-citation></ref><ref id="B12-ijms-15-13494"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guttman</surname><given-names>M.</given-names></name><name><surname>Amit</surname><given-names>I.</given-names></name><name><surname>Garber</surname><given-names>M.</given-names></name><name><surname>French</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>M.F.</given-names></name><name><surname>Feldser</surname><given-names>D.</given-names></name><name><surname>Huarte</surname><given-names>M.</given-names></name><name><surname>Zuk</surname><given-names>O.</given-names></name><name><surname>Carey</surname><given-names>B.W.</given-names></name><name><surname>Cassady</surname><given-names>J.P.</given-names></name><etal/></person-group>
<article-title>Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals</article-title>
<source>Nature</source>
<year>2009</year>
<volume>458</volume>
<fpage>223</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1038/nature07672</pub-id>
<pub-id pub-id-type="pmid">19182780</pub-id></element-citation></ref><ref id="B13-ijms-15-13494"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chew</surname><given-names>G.L.</given-names></name><name><surname>Pauli</surname><given-names>A.</given-names></name><name><surname>Rinn</surname><given-names>J.L.</given-names></name><name><surname>Regev</surname><given-names>A.</given-names></name><name><surname>Schier</surname><given-names>A.F.</given-names></name><name><surname>Valen</surname><given-names>E.</given-names></name></person-group>
<article-title>Ribosome profiling reveals resemblance between long non-coding RNAs and 5' leaders of coding RNAs</article-title>
<source>Development</source>
<year>2013</year>
<volume>140</volume>
<fpage>2828</fpage>
<lpage>2834</lpage>
<pub-id pub-id-type="doi">10.1242/dev.098343</pub-id>
<pub-id pub-id-type="pmid">23698349</pub-id></element-citation></ref><ref id="B14-ijms-15-13494"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cabili</surname><given-names>M.N.</given-names></name><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Goff</surname><given-names>L.</given-names></name><name><surname>Koziol</surname><given-names>M.</given-names></name><name><surname>Tazon-Vega</surname><given-names>B.</given-names></name><name><surname>Regev</surname><given-names>A.</given-names></name><name><surname>Rinn</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses</article-title>
<source>Genes Dev.</source>
<year>2011</year>
<volume>25</volume>
<fpage>1915</fpage>
<lpage>1927</lpage>
<pub-id pub-id-type="doi">10.1101/gad.17446611</pub-id>
<pub-id pub-id-type="pmid">21890647</pub-id></element-citation></ref><ref id="B15-ijms-15-13494"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guttman</surname><given-names>M.</given-names></name><name><surname>Russell</surname><given-names>P.</given-names></name><name><surname>Ingolia</surname><given-names>N.T.</given-names></name><name><surname>Weissman</surname><given-names>J.S.</given-names></name><name><surname>Lander</surname><given-names>E.S.</given-names></name></person-group>
<article-title>Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins</article-title>
<source>Cell</source>
<year>2013</year>
<volume>154</volume>
<fpage>240</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.06.009</pub-id>
<pub-id pub-id-type="pmid">23810193</pub-id></element-citation></ref><ref id="B16-ijms-15-13494"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castelnuovo</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name><name><surname>Guffanti</surname><given-names>E.</given-names></name><name><surname>Infantino</surname><given-names>V.</given-names></name><name><surname>Stutz</surname><given-names>F.</given-names></name><name><surname>Zenklusen</surname><given-names>D.</given-names></name></person-group>
<article-title>Bimodal expression of PHO84 is modulated by early termination of antisense transcription</article-title>
<source>Nat. Struct. Mol. Biol.</source>
<year>2013</year>
<volume>20</volume>
<fpage>851</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.2598</pub-id>
<pub-id pub-id-type="pmid">23770821</pub-id></element-citation></ref><ref id="B17-ijms-15-13494"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camblong</surname><given-names>J.</given-names></name><name><surname>Iglesias</surname><given-names>N.</given-names></name><name><surname>Fickentscher</surname><given-names>C.</given-names></name><name><surname>Dieppois</surname><given-names>G.</given-names></name><name><surname>Stutz</surname><given-names>F.</given-names></name></person-group>
<article-title>Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in <italic>S. Cerevisiae</italic></article-title>
<source>Cell</source>
<year>2007</year>
<volume>131</volume>
<fpage>706</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.09.014</pub-id>
<pub-id pub-id-type="pmid">18022365</pub-id></element-citation></ref><ref id="B18-ijms-15-13494"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martens</surname><given-names>J.A.</given-names></name><name><surname>Laprade</surname><given-names>L.</given-names></name><name><surname>Winston</surname><given-names>F.</given-names></name></person-group>
<article-title>Intergenic transcription is required to repress the saccharomyces cerevisiae SER3 gene</article-title>
<source>Nature</source>
<year>2004</year>
<volume>429</volume>
<fpage>571</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1038/nature02538</pub-id>
<pub-id pub-id-type="pmid">15175754</pub-id></element-citation></ref><ref id="B19-ijms-15-13494"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hung</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>M.F.</given-names></name><name><surname>Koegel</surname><given-names>A.K.</given-names></name><name><surname>Kotake</surname><given-names>Y.</given-names></name><name><surname>Grant</surname><given-names>G.D.</given-names></name><name><surname>Horlings</surname><given-names>H.M.</given-names></name><name><surname>Shah</surname><given-names>N.</given-names></name><name><surname>Umbricht</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><etal/></person-group>
<article-title>Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters</article-title>
<source>Nat. Genet.</source>
<year>2011</year>
<volume>43</volume>
<fpage>621</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1038/ng.848</pub-id>
<pub-id pub-id-type="pmid">21642992</pub-id></element-citation></ref><ref id="B20-ijms-15-13494"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>MicroRNAs: Genomics, biogenesis, mechanism, and function</article-title>
<source>Cell</source>
<year>2004</year>
<volume>116</volume>
<fpage>281</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(04)00045-5</pub-id>
<pub-id pub-id-type="pmid">14744438</pub-id></element-citation></ref><ref id="B21-ijms-15-13494"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sonkoly</surname><given-names>E.</given-names></name><name><surname>Stahle</surname><given-names>M.</given-names></name><name><surname>Pivarcsi</surname><given-names>A.</given-names></name></person-group>
<article-title>MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation</article-title>
<source>Semin. Cancer Biol.</source>
<year>2008</year>
<volume>18</volume>
<fpage>131</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcancer.2008.01.005</pub-id>
<pub-id pub-id-type="pmid">18291670</pub-id></element-citation></ref><ref id="B22-ijms-15-13494"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grimson</surname><given-names>A.</given-names></name><name><surname>Farh</surname><given-names>K.K.</given-names></name><name><surname>Johnston</surname><given-names>W.K.</given-names></name><name><surname>Garrett-Engele</surname><given-names>P.</given-names></name><name><surname>Lim</surname><given-names>L.P.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>MicroRNA targeting specificity in mammals: Determinants beyond seed pairing</article-title>
<source>Mol. Cell</source>
<year>2007</year>
<volume>27</volume>
<fpage>91</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2007.06.017</pub-id>
<pub-id pub-id-type="pmid">17612493</pub-id></element-citation></ref><ref id="B23-ijms-15-13494"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>L.P.</given-names></name><name><surname>Lau</surname><given-names>N.C.</given-names></name><name><surname>Garrett-Engele</surname><given-names>P.</given-names></name><name><surname>Grimson</surname><given-names>A.</given-names></name><name><surname>Schelter</surname><given-names>J.M.</given-names></name><name><surname>Castle</surname><given-names>J.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name><name><surname>Linsley</surname><given-names>P.S.</given-names></name><name><surname>Johnson</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Microarray analysis shows that some microRNAs downregulate large numbers of Target mRNAs</article-title>
<source>Nature</source>
<year>2005</year>
<volume>433</volume>
<fpage>769</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="doi">10.1038/nature03315</pub-id>
<pub-id pub-id-type="pmid">15685193</pub-id></element-citation></ref><ref id="B24-ijms-15-13494"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Yeom</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Baek</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>V.N.</given-names></name></person-group>
<article-title>MicroRNA genes are transcribed by RNA polymerase II</article-title>
<source>EMBO J.</source>
<year>2004</year>
<volume>23</volume>
<fpage>4051</fpage>
<lpage>4060</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7600385</pub-id>
<pub-id pub-id-type="pmid">15372072</pub-id></element-citation></ref><ref id="B25-ijms-15-13494"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wightman</surname><given-names>B.</given-names></name><name><surname>Ha</surname><given-names>I.</given-names></name><name><surname>Ruvkun</surname><given-names>G.</given-names></name></person-group>
<article-title>Posttranscriptional regulation of the heterochronic gene Lin-14 by Lin-4 mediates temporal pattern formation in <italic>C. Elegans</italic></article-title>
<source>Cell</source>
<year>1993</year>
<volume>75</volume>
<fpage>855</fpage>
<lpage>862</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(93)90530-4</pub-id>
<pub-id pub-id-type="pmid">8252622</pub-id></element-citation></ref><ref id="B26-ijms-15-13494"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>R.M.</given-names></name><name><surname>Rao</surname><given-names>D.S.</given-names></name><name><surname>Chaudhuri</surname><given-names>A.A.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group>
<article-title>Physiological and pathological roles for microRNAs in the immune system</article-title>
<source>Nat. Rev. Immunol.</source>
<year>2010</year>
<volume>10</volume>
<fpage>111</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1038/nri2708</pub-id>
<pub-id pub-id-type="pmid">20098459</pub-id></element-citation></ref><ref id="B27-ijms-15-13494"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>K.C.</given-names></name><name><surname>Rye</surname><given-names>K.A.</given-names></name><name><surname>Tabet</surname><given-names>F.</given-names></name></person-group>
<article-title>MicroRNAs in the onset and development of cardiovascular disease</article-title>
<source>Clin. Sci.</source>
<year>2014</year>
<volume>126</volume>
<fpage>183</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1042/CS20130203</pub-id>
<pub-id pub-id-type="pmid">24102098</pub-id></element-citation></ref><ref id="B28-ijms-15-13494"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ouimet</surname><given-names>M.</given-names></name><name><surname>Moore</surname><given-names>K.J.</given-names></name></person-group>
<article-title>A big role for small RNAs in HDL homeostasis</article-title>
<source>J. Lipid Res.</source>
<year>2013</year>
<volume>54</volume>
<fpage>1161</fpage>
<lpage>1167</lpage>
<pub-id pub-id-type="doi">10.1194/jlr.R036327</pub-id>
<pub-id pub-id-type="pmid">23509405</pub-id></element-citation></ref><ref id="B29-ijms-15-13494"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ladewig</surname><given-names>E.</given-names></name><name><surname>Okamura</surname><given-names>K.</given-names></name><name><surname>Flynt</surname><given-names>A.S.</given-names></name><name><surname>Westholm</surname><given-names>J.O.</given-names></name><name><surname>Lai</surname><given-names>E.C.</given-names></name></person-group>
<article-title>Discovery of hundreds of mirtrons in mouse and human small RNA data</article-title>
<source>Genome Res.</source>
<year>2012</year>
<volume>22</volume>
<fpage>1634</fpage>
<lpage>1645</lpage>
<pub-id pub-id-type="doi">10.1101/gr.133553.111</pub-id>
<pub-id pub-id-type="pmid">22955976</pub-id></element-citation></ref><ref id="B30-ijms-15-13494"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Ahn</surname><given-names>C.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Yim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Provost</surname><given-names>P.</given-names></name><name><surname>Radmark</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>The nuclear RNase III Drosha initiates microRNA processing</article-title>
<source>Nature</source>
<year>2003</year>
<volume>425</volume>
<fpage>415</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1038/nature01957</pub-id>
<pub-id pub-id-type="pmid">14508493</pub-id></element-citation></ref><ref id="B31-ijms-15-13494"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Yeom</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>V.N.</given-names></name></person-group>
<article-title>The Drosha-DGCR8 complex in primary microRNA processing</article-title>
<source>Genes Dev.</source>
<year>2004</year>
<volume>18</volume>
<fpage>3016</fpage>
<lpage>3027</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1262504</pub-id>
<pub-id pub-id-type="pmid">15574589</pub-id></element-citation></ref><ref id="B32-ijms-15-13494"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lund</surname><given-names>E.</given-names></name><name><surname>Guttinger</surname><given-names>S.</given-names></name><name><surname>Calado</surname><given-names>A.</given-names></name><name><surname>Dahlberg</surname><given-names>J.E.</given-names></name><name><surname>Kutay</surname><given-names>U.</given-names></name></person-group>
<article-title>Nuclear export of microRNA precursors</article-title>
<source>Science</source>
<year>2004</year>
<volume>303</volume>
<fpage>95</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1126/science.1090599</pub-id>
<pub-id pub-id-type="pmid">14631048</pub-id></element-citation></ref><ref id="B33-ijms-15-13494"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hutvagner</surname><given-names>G.</given-names></name><name><surname>McLachlan</surname><given-names>J.</given-names></name><name><surname>Pasquinelli</surname><given-names>A.E.</given-names></name><name><surname>Balint</surname><given-names>E.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name><name><surname>Zamore</surname><given-names>P.D.</given-names></name></person-group>
<article-title>A cellular function for the RNA-Interference enzyme dicer in the maturation of the Let-7 small temporal RNA</article-title>
<source>Science</source>
<year>2001</year>
<volume>293</volume>
<fpage>834</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="doi">10.1126/science.1062961</pub-id>
<pub-id pub-id-type="pmid">11452083</pub-id></element-citation></ref><ref id="B34-ijms-15-13494"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>R.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Macara</surname><given-names>I.G.</given-names></name><name><surname>Cullen</surname><given-names>B.R.</given-names></name></person-group>
<article-title>Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs</article-title>
<source>Genes Dev.</source>
<year>2003</year>
<volume>17</volume>
<fpage>3011</fpage>
<lpage>3016</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1158803</pub-id>
<pub-id pub-id-type="pmid">14681208</pub-id></element-citation></ref><ref id="B35-ijms-15-13494"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Ingolia</surname><given-names>N.T.</given-names></name><name><surname>Weissman</surname><given-names>J.S.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>Mammalian microRNAs predominantly act to decrease target mRNA levels</article-title>
<source>Nature</source>
<year>2010</year>
<volume>466</volume>
<fpage>835</fpage>
<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1038/nature09267</pub-id>
<pub-id pub-id-type="pmid">20703300</pub-id></element-citation></ref><ref id="B36-ijms-15-13494"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>MicroRNAs: Target recognition and regulatory functions</article-title>
<source>Cell</source>
<year>2009</year>
<volume>136</volume>
<fpage>215</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id>
<pub-id pub-id-type="pmid">19167326</pub-id></element-citation></ref><ref id="B37-ijms-15-13494"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P.S.</given-names></name><name><surname>Parkin</surname><given-names>R.K.</given-names></name><name><surname>Kroh</surname><given-names>E.M.</given-names></name><name><surname>Fritz</surname><given-names>B.R.</given-names></name><name><surname>Wyman</surname><given-names>S.K.</given-names></name><name><surname>Pogosova-Agadjanyan</surname><given-names>E.L.</given-names></name><name><surname>Peterson</surname><given-names>A.</given-names></name><name><surname>Noteboom</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Briant</surname><given-names>K.C.</given-names></name><name><surname>Allen</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Circulating microRNAs as stable blood-based markers for cancer detection</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2008</year>
<volume>105</volume>
<fpage>10513</fpage>
<lpage>10518</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0804549105</pub-id>
<pub-id pub-id-type="pmid">18663219</pub-id></element-citation></ref><ref id="B38-ijms-15-13494"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fichtlscherer</surname><given-names>S.</given-names></name><name><surname>Zeiher</surname><given-names>A.M.</given-names></name><name><surname>Dimmeler</surname><given-names>S.</given-names></name></person-group>
<article-title>Circulating microRNAs: Biomarkers or mediators of cardiovascular diseases?</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2011</year>
<volume>31</volume>
<fpage>2383</fpage>
<lpage>2390</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.226696</pub-id>
<pub-id pub-id-type="pmid">22011751</pub-id></element-citation></ref><ref id="B39-ijms-15-13494"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Sanagawa</surname><given-names>A.</given-names></name><name><surname>Mori</surname><given-names>C.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Iwaki</surname><given-names>S.</given-names></name><name><surname>Satoh</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>S.</given-names></name></person-group>
<article-title>Circulating microRNA-126 in patients with coronary artery disease: Correlation with LDL cholesterol</article-title>
<source>Thromb. J.</source>
<year>2012</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.1186/1477-9560-10-16</pub-id>
</element-citation></ref><ref id="B40-ijms-15-13494"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>K.C.</given-names></name><name><surname>Remaley</surname><given-names>A.T.</given-names></name></person-group>
<article-title>Lipid-based carriers of microRNAs and intercellular communication</article-title>
<source>Curr. Opin. Lipidol.</source>
<year>2012</year>
<volume>23</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1097/MOL.0b013e328350a425</pub-id>
<pub-id pub-id-type="pmid">22418571</pub-id></element-citation></ref><ref id="B41-ijms-15-13494"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>K.C.</given-names></name><name><surname>Palmisano</surname><given-names>B.T.</given-names></name><name><surname>Shoucri</surname><given-names>B.M.</given-names></name><name><surname>Shamburek</surname><given-names>R.D.</given-names></name><name><surname>Remaley</surname><given-names>A.T.</given-names></name></person-group>
<article-title>MicroRNAs are transported in plasma and delivered to recipient Cells by high-density lipoproteins</article-title>
<source>Nat. Cell Biol.</source>
<year>2011</year>
<volume>13</volume>
<fpage>423</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1038/ncb2210</pub-id>
<pub-id pub-id-type="pmid">21423178</pub-id></element-citation></ref><ref id="B42-ijms-15-13494"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barter</surname><given-names>P.</given-names></name><name><surname>Gotto</surname><given-names>A.M.</given-names></name><name><surname>LaRosa</surname><given-names>J.C.</given-names></name><name><surname>Maroni</surname><given-names>J.</given-names></name><name><surname>Szarek</surname><given-names>M.</given-names></name><name><surname>Grundy</surname><given-names>S.M.</given-names></name><name><surname>Kastelein</surname><given-names>J.J.</given-names></name><name><surname>Bittner</surname><given-names>V.</given-names></name><name><surname>Fruchart</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Treating to new targets investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events</article-title>
<source>N. Engl. J. Med.</source>
<year>2007</year>
<volume>357</volume>
<fpage>1301</fpage>
<lpage>1310</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa064278</pub-id>
<pub-id pub-id-type="pmid">17898099</pub-id></element-citation></ref><ref id="B43-ijms-15-13494"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Dahlman-Wright</surname><given-names>K.</given-names></name></person-group>
<article-title>Liver X receptor in cholesterol metabolism</article-title>
<source>J. Endocrinol.</source>
<year>2010</year>
<volume>204</volume>
<fpage>233</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1677/JOE-09-0271</pub-id>
<pub-id pub-id-type="pmid">19837721</pub-id></element-citation></ref><ref id="B44-ijms-15-13494"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Min</surname><given-names>H.K.</given-names></name><name><surname>Kapoor</surname><given-names>A.</given-names></name><name><surname>Fuchs</surname><given-names>M.</given-names></name><name><surname>Mirshahi</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Maher</surname><given-names>J.</given-names></name><name><surname>Kellum</surname><given-names>J.</given-names></name><name><surname>Warnick</surname><given-names>R.</given-names></name><name><surname>Contos</surname><given-names>M.J.</given-names></name><name><surname>Sanyal</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease</article-title>
<source>Cell Metab.</source>
<year>2012</year>
<volume>15</volume>
<fpage>665</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2012.04.004</pub-id>
<pub-id pub-id-type="pmid">22560219</pub-id></element-citation></ref><ref id="B45-ijms-15-13494"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esau</surname><given-names>C.</given-names></name><name><surname>Davis</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>S.F.</given-names></name><name><surname>Yu</surname><given-names>X.X.</given-names></name><name><surname>Pandey</surname><given-names>S.K.</given-names></name><name><surname>Pear</surname><given-names>M.</given-names></name><name><surname>Watts</surname><given-names>L.</given-names></name><name><surname>Booten</surname><given-names>S.L.</given-names></name><name><surname>Graham</surname><given-names>M.</given-names></name><name><surname>McKay</surname><given-names>R.</given-names></name><etal/></person-group>
<article-title>MiR-122 regulation of lipid metabolism revealed by <italic>in vivo</italic> antisense targeting</article-title>
<source>Cell Metab.</source>
<year>2006</year>
<volume>3</volume>
<fpage>87</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2006.01.005</pub-id>
<pub-id pub-id-type="pmid">16459310</pub-id></element-citation></ref><ref id="B46-ijms-15-13494"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moore</surname><given-names>K.J.</given-names></name><name><surname>Rayner</surname><given-names>K.J.</given-names></name><name><surname>Suarez</surname><given-names>Y.</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C.</given-names></name></person-group>
<article-title>MicroRNAs and cholesterol metabolism</article-title>
<source>Trends Endocrinol. Metab.</source>
<year>2010</year>
<volume>21</volume>
<fpage>699</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="doi">10.1016/j.tem.2010.08.008</pub-id>
<pub-id pub-id-type="pmid">20880716</pub-id></element-citation></ref><ref id="B47-ijms-15-13494"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>K.C.</given-names></name><name><surname>Shoucri</surname><given-names>B.M.</given-names></name><name><surname>Levin</surname><given-names>M.G.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Pearson</surname><given-names>D.S.</given-names></name><name><surname>Osei-Hwedieh</surname><given-names>D.</given-names></name><name><surname>Collins</surname><given-names>F.S.</given-names></name><name><surname>Remaley</surname><given-names>A.T.</given-names></name><name><surname>Sethupathy</surname><given-names>P.</given-names></name></person-group>
<article-title>MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia</article-title>
<source>Hepatology</source>
<year>2013</year>
<volume>57</volume>
<fpage>533</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1002/hep.25846</pub-id>
<pub-id pub-id-type="pmid">22777896</pub-id></element-citation></ref><ref id="B48-ijms-15-13494"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kida</surname><given-names>K.</given-names></name><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Mohri</surname><given-names>T.</given-names></name><name><surname>Oda</surname><given-names>Y.</given-names></name><name><surname>Takagi</surname><given-names>S.</given-names></name><name><surname>Fukami</surname><given-names>T.</given-names></name><name><surname>Yokoi</surname><given-names>T.</given-names></name></person-group>
<article-title>PPARalpha is regulated by miR-21 and miR-27b in human liver</article-title>
<source>Pharm. Res.</source>
<year>2011</year>
<volume>28</volume>
<fpage>2467</fpage>
<lpage>2476</lpage>
<pub-id pub-id-type="doi">10.1007/s11095-011-0473-y</pub-id>
<pub-id pub-id-type="pmid">21562928</pub-id></element-citation></ref><ref id="B49-ijms-15-13494"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>G.C.</given-names></name><name><surname>Sheng</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.D.</given-names></name></person-group>
<article-title>Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-&#x003b1; expression, a novel mechanism for the pathogenesis of NAFLD</article-title>
<source>J. Gastroenterol. Hepatol.</source>
<year>2010</year>
<volume>25</volume>
<fpage>156</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.05949.x</pub-id>
<pub-id pub-id-type="pmid">19780876</pub-id></element-citation></ref><ref id="B50-ijms-15-13494"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>K.J.</given-names></name><name><surname>Sheedy</surname><given-names>F.J.</given-names></name><name><surname>Esau</surname><given-names>C.C.</given-names></name><name><surname>Hussain</surname><given-names>F.N.</given-names></name><name><surname>Temel</surname><given-names>R.E.</given-names></name><name><surname>Parathath</surname><given-names>S.</given-names></name><name><surname>van Gils</surname><given-names>J.M.</given-names></name><name><surname>Rayner</surname><given-names>A.J.</given-names></name><name><surname>Chang</surname><given-names>A.N.</given-names></name><name><surname>Suarez</surname><given-names>Y.</given-names></name><etal/></person-group>
<article-title>Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis</article-title>
<source>J. Clin. Investig.</source>
<year>2011</year>
<volume>121</volume>
<fpage>2921</fpage>
<lpage>2931</lpage>
<pub-id pub-id-type="doi">10.1172/JCI57275</pub-id>
<pub-id pub-id-type="pmid">21646721</pub-id></element-citation></ref><ref id="B51-ijms-15-13494"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>K.J.</given-names></name><name><surname>Suarez</surname><given-names>Y.</given-names></name><name><surname>Davalos</surname><given-names>A.</given-names></name><name><surname>Parathath</surname><given-names>S.</given-names></name><name><surname>Fitzgerald</surname><given-names>M.L.</given-names></name><name><surname>Tamehiro</surname><given-names>N.</given-names></name><name><surname>Fisher</surname><given-names>E.A.</given-names></name><name><surname>Moore</surname><given-names>K.J.</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C.</given-names></name></person-group>
<article-title>MiR-33 contributes to the regulation of cholesterol homeostasis</article-title>
<source>Science</source>
<year>2010</year>
<volume>328</volume>
<fpage>1570</fpage>
<lpage>1573</lpage>
<pub-id pub-id-type="doi">10.1126/science.1189862</pub-id>
<pub-id pub-id-type="pmid">20466885</pub-id></element-citation></ref><ref id="B52-ijms-15-13494"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marquart</surname><given-names>T.J.</given-names></name><name><surname>Allen</surname><given-names>R.M.</given-names></name><name><surname>Ory</surname><given-names>D.S.</given-names></name><name><surname>Baldan</surname><given-names>A.</given-names></name></person-group>
<article-title>MiR-33 links SREBP-2 induction to repression of sterol transporters</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2010</year>
<volume>107</volume>
<fpage>12228</fpage>
<lpage>12232</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1005191107</pub-id>
<pub-id pub-id-type="pmid">20566875</pub-id></element-citation></ref><ref id="B53-ijms-15-13494"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerin</surname><given-names>I.</given-names></name><name><surname>Clerbaux</surname><given-names>L.A.</given-names></name><name><surname>Haumont</surname><given-names>O.</given-names></name><name><surname>Lanthier</surname><given-names>N.</given-names></name><name><surname>Das</surname><given-names>A.K.</given-names></name><name><surname>Burant</surname><given-names>C.F.</given-names></name><name><surname>Leclercq</surname><given-names>I.A.</given-names></name><name><surname>MacDougald</surname><given-names>O.A.</given-names></name><name><surname>Bommer</surname><given-names>G.T.</given-names></name></person-group>
<article-title>Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation</article-title>
<source>J. Biol. Chem.</source>
<year>2010</year>
<volume>285</volume>
<fpage>33652</fpage>
<lpage>33661</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.152090</pub-id>
<pub-id pub-id-type="pmid">20732877</pub-id></element-citation></ref><ref id="B54-ijms-15-13494"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horie</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Horiguchi</surname><given-names>M.</given-names></name><name><surname>Nishi</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Nagao</surname><given-names>K.</given-names></name><name><surname>Kinoshita</surname><given-names>M.</given-names></name><name><surname>Kuwabara</surname><given-names>Y.</given-names></name><name><surname>Marusawa</surname><given-names>H.</given-names></name><name><surname>Iwanaga</surname><given-names>Y.</given-names></name><etal/></person-group>
<article-title>MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL <italic>in vivo</italic></article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2010</year>
<volume>107</volume>
<fpage>17321</fpage>
<lpage>17326</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1008499107</pub-id>
<pub-id pub-id-type="pmid">20855588</pub-id></element-citation></ref><ref id="B55-ijms-15-13494"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Najafi-Shoushtari</surname><given-names>S.H.</given-names></name><name><surname>Kristo</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shioda</surname><given-names>T.</given-names></name><name><surname>Cohen</surname><given-names>D.E.</given-names></name><name><surname>Gerszten</surname><given-names>R.E.</given-names></name><name><surname>Naar</surname><given-names>A.M.</given-names></name></person-group>
<article-title>MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis</article-title>
<source>Science</source>
<year>2010</year>
<volume>328</volume>
<fpage>1566</fpage>
<lpage>1569</lpage>
<pub-id pub-id-type="doi">10.1126/science.1189123</pub-id>
<pub-id pub-id-type="pmid">20466882</pub-id></element-citation></ref><ref id="B56-ijms-15-13494"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Espenshade</surname><given-names>P.J.</given-names></name><name><surname>Hughes</surname><given-names>A.L.</given-names></name></person-group>
<article-title>Regulation of sterol synthesis in eukaryotes</article-title>
<source>Annu. Rev. Genet.</source>
<year>2007</year>
<volume>41</volume>
<fpage>401</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.genet.41.110306.130315</pub-id>
<pub-id pub-id-type="pmid">17666007</pub-id></element-citation></ref><ref id="B57-ijms-15-13494"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>R.M.</given-names></name><name><surname>Marquart</surname><given-names>T.J.</given-names></name><name><surname>Albert</surname><given-names>C.J.</given-names></name><name><surname>Suchy</surname><given-names>F.J.</given-names></name><name><surname>Wang</surname><given-names>D.Q.</given-names></name><name><surname>Ananthanarayanan</surname><given-names>M.</given-names></name><name><surname>Ford</surname><given-names>D.A.</given-names></name><name><surname>Baldan</surname><given-names>A.</given-names></name></person-group>
<article-title>MiR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity</article-title>
<source>EMBO Mol. Med.</source>
<year>2012</year>
<volume>4</volume>
<fpage>882</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="doi">10.1002/emmm.201201228</pub-id>
<pub-id pub-id-type="pmid">22767443</pub-id></element-citation></ref><ref id="B58-ijms-15-13494"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davalos</surname><given-names>A.</given-names></name><name><surname>Goedeke</surname><given-names>L.</given-names></name><name><surname>Smibert</surname><given-names>P.</given-names></name><name><surname>Ramirez</surname><given-names>C.M.</given-names></name><name><surname>Warrier</surname><given-names>N.P.</given-names></name><name><surname>Andreo</surname><given-names>U.</given-names></name><name><surname>Cirera-Salinas</surname><given-names>D.</given-names></name><name><surname>Rayner</surname><given-names>K.</given-names></name><name><surname>Suresh</surname><given-names>U.</given-names></name><name><surname>Pastor-Pareja</surname><given-names>J.C.</given-names></name><etal/></person-group>
<article-title>MiR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2011</year>
<volume>108</volume>
<fpage>9232</fpage>
<lpage>9237</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1102281108</pub-id>
<pub-id pub-id-type="pmid">21576456</pub-id></element-citation></ref><ref id="B59-ijms-15-13494"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>K.J.</given-names></name><name><surname>Esau</surname><given-names>C.C.</given-names></name><name><surname>Hussain</surname><given-names>F.N.</given-names></name><name><surname>McDaniel</surname><given-names>A.L.</given-names></name><name><surname>Marshall</surname><given-names>S.M.</given-names></name><name><surname>van Gils</surname><given-names>J.M.</given-names></name><name><surname>Ray</surname><given-names>T.D.</given-names></name><name><surname>Sheedy</surname><given-names>F.J.</given-names></name><name><surname>Goedeke</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group>
<article-title>Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides</article-title>
<source>Nature</source>
<year>2011</year>
<volume>478</volume>
<fpage>404</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1038/nature10486</pub-id>
<pub-id pub-id-type="pmid">22012398</pub-id></element-citation></ref><ref id="B60-ijms-15-13494"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elmen</surname><given-names>J.</given-names></name><name><surname>Lindow</surname><given-names>M.</given-names></name><name><surname>Schutz</surname><given-names>S.</given-names></name><name><surname>Lawrence</surname><given-names>M.</given-names></name><name><surname>Petri</surname><given-names>A.</given-names></name><name><surname>Obad</surname><given-names>S.</given-names></name><name><surname>Lindholm</surname><given-names>M.</given-names></name><name><surname>Hedtjarn</surname><given-names>M.</given-names></name><name><surname>Hansen</surname><given-names>H.F.</given-names></name><name><surname>Berger</surname><given-names>U.</given-names></name><etal/></person-group>
<article-title>LNA-mediated microRNA silencing in non-human primates</article-title>
<source>Nature</source>
<year>2008</year>
<volume>452</volume>
<fpage>896</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="doi">10.1038/nature06783</pub-id>
<pub-id pub-id-type="pmid">18368051</pub-id></element-citation></ref><ref id="B61-ijms-15-13494"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elmen</surname><given-names>J.</given-names></name><name><surname>Lindow</surname><given-names>M.</given-names></name><name><surname>Silahtaroglu</surname><given-names>A.</given-names></name><name><surname>Bak</surname><given-names>M.</given-names></name><name><surname>Christensen</surname><given-names>M.</given-names></name><name><surname>Lind-Thomsen</surname><given-names>A.</given-names></name><name><surname>Hedtjarn</surname><given-names>M.</given-names></name><name><surname>Hansen</surname><given-names>J.B.</given-names></name><name><surname>Hansen</surname><given-names>H.F.</given-names></name><name><surname>Straarup</surname><given-names>E.M.</given-names></name><etal/></person-group>
<article-title>Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver</article-title>
<source>Nucleic Acids Res.</source>
<year>2008</year>
<volume>36</volume>
<fpage>1153</fpage>
<lpage>1162</lpage>
<pub-id pub-id-type="pmid">18158304</pub-id></element-citation></ref><ref id="B62-ijms-15-13494"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krutzfeldt</surname><given-names>J.</given-names></name><name><surname>Rajewsky</surname><given-names>N.</given-names></name><name><surname>Braich</surname><given-names>R.</given-names></name><name><surname>Rajeev</surname><given-names>K.G.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name><name><surname>Manoharan</surname><given-names>M.</given-names></name><name><surname>Stoffel</surname><given-names>M.</given-names></name></person-group>
<article-title>Silencing of microRNAs <italic>in vivo</italic> with &#x0201c;antagomirs&#x0201d;</article-title>
<source>Nature</source>
<year>2005</year>
<volume>438</volume>
<fpage>685</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="doi">10.1038/nature04303</pub-id>
<pub-id pub-id-type="pmid">16258535</pub-id></element-citation></ref><ref id="B63-ijms-15-13494"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S.H.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Kota</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Costinean</surname><given-names>S.</given-names></name><name><surname>Kutay</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>S.</given-names></name><name><surname>La Perle</surname><given-names>K.</given-names></name><name><surname>Chivukula</surname><given-names>R.R.</given-names></name><etal/></person-group>
<article-title>Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver</article-title>
<source>J. Clin. Investig.</source>
<year>2012</year>
<volume>122</volume>
<fpage>2871</fpage>
<lpage>2883</lpage>
<pub-id pub-id-type="doi">10.1172/JCI63539</pub-id>
<pub-id pub-id-type="pmid">22820288</pub-id></element-citation></ref><ref id="B64-ijms-15-13494"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsai</surname><given-names>W.C.</given-names></name><name><surname>Hsu</surname><given-names>S.D.</given-names></name><name><surname>Hsu</surname><given-names>C.S.</given-names></name><name><surname>Lai</surname><given-names>T.C.</given-names></name><name><surname>Chen</surname><given-names>S.J.</given-names></name><name><surname>Shen</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.C.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name><name><surname>Tsai</surname><given-names>T.F.</given-names></name><etal/></person-group>
<article-title>MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis</article-title>
<source>J. Clin. Investig.</source>
<year>2012</year>
<volume>122</volume>
<fpage>2884</fpage>
<lpage>2897</lpage>
<pub-id pub-id-type="doi">10.1172/JCI63455</pub-id>
<pub-id pub-id-type="pmid">22820290</pub-id></element-citation></ref><ref id="B65-ijms-15-13494"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>C.M.</given-names></name><name><surname>Rotllan</surname><given-names>N.</given-names></name><name><surname>Vlassov</surname><given-names>A.V.</given-names></name><name><surname>Davalos</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Goedeke</surname><given-names>L.</given-names></name><name><surname>Aranda</surname><given-names>J.F.</given-names></name><name><surname>Cirera-Salinas</surname><given-names>D.</given-names></name><name><surname>Araldi</surname><given-names>E.</given-names></name><name><surname>Salerno</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144</article-title>
<source>Circ. Res.</source>
<year>2013</year>
<volume>112</volume>
<fpage>1592</fpage>
<lpage>1601</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300626</pub-id>
<pub-id pub-id-type="pmid">23519695</pub-id></element-citation></ref><ref id="B66-ijms-15-13494"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>C.M.</given-names></name><name><surname>Davalos</surname><given-names>A.</given-names></name><name><surname>Goedeke</surname><given-names>L.</given-names></name><name><surname>Salerno</surname><given-names>A.G.</given-names></name><name><surname>Warrier</surname><given-names>N.</given-names></name><name><surname>Cirera-Salinas</surname><given-names>D.</given-names></name><name><surname>Suarez</surname><given-names>Y.</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C.</given-names></name></person-group>
<article-title>MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2011</year>
<volume>31</volume>
<fpage>2707</fpage>
<lpage>2714</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.232066</pub-id>
<pub-id pub-id-type="pmid">21885853</pub-id></element-citation></ref><ref id="B67-ijms-15-13494"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>H.</given-names></name><name><surname>Ramirez</surname><given-names>C.M.</given-names></name><name><surname>Lee</surname><given-names>S.M.</given-names></name><name><surname>Hoe</surname><given-names>H.S.</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group>
<article-title>MiR-106b impairs cholesterol efflux and increases A&#x003b2; levels by repressing ABCA1 expression</article-title>
<source>Exp. Neurol.</source>
<year>2012</year>
<volume>235</volume>
<fpage>476</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2011.11.010</pub-id>
<pub-id pub-id-type="pmid">22119192</pub-id></element-citation></ref><ref id="B68-ijms-15-13494"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name></person-group>
<article-title>MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7</article-title>
<source>FEBS Lett.</source>
<year>2012</year>
<volume>586</volume>
<fpage>1472</fpage>
<lpage>1479</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2012.03.068</pub-id>
<pub-id pub-id-type="pmid">22673513</pub-id></element-citation></ref><ref id="B69-ijms-15-13494"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhong</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name></person-group>
<article-title>MicroRNA-1 and microRNA-206 suppress LXR&#x003b1;-Induced Lipogenesis in Hepatocytes</article-title>
<source>Cell Signal.</source>
<year>2013</year>
<volume>25</volume>
<fpage>1429</fpage>
<lpage>1437</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2013.03.003</pub-id>
<pub-id pub-id-type="pmid">23499676</pub-id></element-citation></ref><ref id="B70-ijms-15-13494"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhong</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>Y.J.</given-names></name><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>G.Z.</given-names></name><name><surname>Hu</surname><given-names>C.J.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>He</surname><given-names>F.T.</given-names></name></person-group>
<article-title>MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXR&#x003b1;</article-title>
<source>Lipids Health Dis.</source>
<year>2013</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.1186/1476-511X-12-32</pub-id>
</element-citation></ref><ref id="B71-ijms-15-13494"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>He</surname><given-names>Y.S.</given-names></name><name><surname>Wang</surname><given-names>X.Q.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Q.J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>W.F.</given-names></name></person-group>
<article-title>MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4</article-title>
<source>FEBS Lett.</source>
<year>2011</year>
<volume>585</volume>
<fpage>854</fpage>
<lpage>860</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2011.02.009</pub-id>
<pub-id pub-id-type="pmid">21329689</pub-id></element-citation></ref><ref id="B72-ijms-15-13494"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name></person-group>
<article-title>MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages</article-title>
<source>Cardiovasc. Res.</source>
<year>2009</year>
<volume>83</volume>
<fpage>131</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvp121</pub-id>
<pub-id pub-id-type="pmid">19377067</pub-id></element-citation></ref><ref id="B73-ijms-15-13494"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.S.</given-names></name><name><surname>Hu</surname><given-names>G.Q.</given-names></name><name><surname>Lin</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>Z.Y.</given-names></name><name><surname>Sun</surname><given-names>C.C.</given-names></name></person-group>
<article-title>MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages</article-title>
<source>J. Investig. Med.</source>
<year>2010</year>
<volume>58</volume>
<fpage>961</fpage>
<lpage>967</lpage>
</element-citation></ref><ref id="B74-ijms-15-13494"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>W.J.</given-names></name><name><surname>Kraemer</surname><given-names>F.B.</given-names></name><name><surname>Azhar</surname><given-names>S.</given-names></name></person-group>
<article-title>MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells</article-title>
<source>Mol. Cell. Biol.</source>
<year>2012</year>
<volume>32</volume>
<fpage>5035</fpage>
<lpage>5045</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.01002-12</pub-id>
<pub-id pub-id-type="pmid">23045399</pub-id></element-citation></ref><ref id="B75-ijms-15-13494"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Jia</surname><given-names>X.J.</given-names></name><name><surname>Jiang</surname><given-names>H.J.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Si</surname><given-names>S.Y.</given-names></name><name><surname>Hong</surname><given-names>B.</given-names></name></person-group>
<article-title>MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition</article-title>
<source>Mol. Cell. Biol.</source>
<year>2013</year>
<volume>33</volume>
<fpage>1956</fpage>
<lpage>1964</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.01580-12</pub-id>
<pub-id pub-id-type="pmid">23459944</pub-id></element-citation></ref><ref id="B76-ijms-15-13494"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Shen</surname><given-names>Z.</given-names></name><name><surname>Flatow</surname><given-names>L.</given-names></name><name><surname>You</surname><given-names>M.</given-names></name></person-group>
<article-title>MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1</article-title>
<source>J. Biol. Chem.</source>
<year>2012</year>
<volume>287</volume>
<fpage>9817</fpage>
<lpage>9826</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.333534</pub-id>
<pub-id pub-id-type="pmid">22308024</pub-id></element-citation></ref><ref id="B77-ijms-15-13494"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>Y.L.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>J.J.</given-names></name><name><surname>Chen</surname><given-names>H.Q.</given-names></name><name><surname>Liu</surname><given-names>Z.H.</given-names></name><name><surname>Peng</surname><given-names>J.Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.K.</given-names></name><name><surname>Qin</surname><given-names>H.L.</given-names></name></person-group>
<article-title>A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis</article-title>
<source>Mol. Biol. Rep.</source>
<year>2012</year>
<volume>39</volume>
<fpage>269</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="pmid">21625865</pub-id></element-citation></ref><ref id="B78-ijms-15-13494"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kapeller</surname><given-names>J.</given-names></name><name><surname>Houghton</surname><given-names>L.A.</given-names></name><name><surname>Monnikes</surname><given-names>H.</given-names></name><name><surname>Walstab</surname><given-names>J.</given-names></name><name><surname>Moller</surname><given-names>D.</given-names></name><name><surname>Bonisch</surname><given-names>H.</given-names></name><name><surname>Burwinkel</surname><given-names>B.</given-names></name><name><surname>Autschbach</surname><given-names>F.</given-names></name><name><surname>Funke</surname><given-names>B.</given-names></name><name><surname>Lasitschka</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome</article-title>
<source>Hum. Mol. Genet.</source>
<year>2008</year>
<volume>17</volume>
<fpage>2967</fpage>
<lpage>2977</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddn195</pub-id>
<pub-id pub-id-type="pmid">18614545</pub-id></element-citation></ref><ref id="B79-ijms-15-13494"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.S.</given-names></name><name><surname>Jeon</surname><given-names>Y.J.</given-names></name><name><surname>Lee</surname><given-names>B.E.</given-names></name><name><surname>Kim</surname><given-names>T.G.</given-names></name><name><surname>Choi</surname><given-names>J.U.</given-names></name><name><surname>Kim</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>N.K.</given-names></name></person-group>
<article-title>Association of the miR-146aC&#x0003e;G, miR-196a2C&#x0003e;T, and miR-499A&#x0003e;G polymorphisms with moyamoya disease in the Korean population</article-title>
<source>Neurosci. Lett.</source>
<year>2012</year>
<volume>521</volume>
<fpage>71</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2012.05.062</pub-id>
<pub-id pub-id-type="pmid">22659075</pub-id></element-citation></ref><ref id="B80-ijms-15-13494"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arnold</surname><given-names>M.</given-names></name><name><surname>Ellwanger</surname><given-names>D.C.</given-names></name><name><surname>Hartsperger</surname><given-names>M.L.</given-names></name><name><surname>Pfeufer</surname><given-names>A.</given-names></name><name><surname>Stumpflen</surname><given-names>V.</given-names></name></person-group>
<article-title>Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways</article-title>
<source>PLoS One</source>
<year>2012</year>
<volume>7</volume>
<fpage>e36694</fpage>
<pub-id pub-id-type="pmid">22606281</pub-id></element-citation></ref><ref id="B81-ijms-15-13494"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fan</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name></person-group>
<article-title>The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis</article-title>
<source>Mol. Biol. Rep.</source>
<year>2013</year>
<volume>40</volume>
<fpage>3389</fpage>
<lpage>3394</lpage>
<pub-id pub-id-type="doi">10.1007/s11033-012-2416-z</pub-id>
<pub-id pub-id-type="pmid">23271127</pub-id></element-citation></ref><ref id="B82-ijms-15-13494"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richardson</surname><given-names>K.</given-names></name><name><surname>Nettleton</surname><given-names>J.A.</given-names></name><name><surname>Rotllan</surname><given-names>N.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Smith</surname><given-names>C.E.</given-names></name><name><surname>Lai</surname><given-names>C.Q.</given-names></name><name><surname>Parnell</surname><given-names>L.D.</given-names></name><name><surname>Lee</surname><given-names>Y.C.</given-names></name><name><surname>Lahti</surname><given-names>J.</given-names></name><name><surname>Lemaitre</surname><given-names>R.N.</given-names></name><etal/></person-group>
<article-title>Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site</article-title>
<source>Am. J. Hum. Genet.</source>
<year>2013</year>
<volume>92</volume>
<fpage>5</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.10.020</pub-id>
<pub-id pub-id-type="pmid">23246289</pub-id></element-citation></ref><ref id="B83-ijms-15-13494"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>G.C.</given-names></name></person-group>
<article-title>Extracellular/circulating microRNAs and their potential role in cardiovascular disease</article-title>
<source>Am. J. Cardiovasc. Dis.</source>
<year>2011</year>
<volume>1</volume>
<fpage>138</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">22059153</pub-id></element-citation></ref><ref id="B84-ijms-15-13494"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Besler</surname><given-names>C.</given-names></name><name><surname>Luscher</surname><given-names>T.F.</given-names></name><name><surname>Landmesser</surname><given-names>U.</given-names></name></person-group>
<article-title>Molecular mechanisms of vascular effects of high-density lipoprotein: Alterations in cardiovascular disease</article-title>
<source>EMBO Mol. Med.</source>
<year>2012</year>
<volume>4</volume>
<fpage>251</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1002/emmm.201200224</pub-id>
<pub-id pub-id-type="pmid">22431312</pub-id></element-citation></ref><ref id="B85-ijms-15-13494"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hansson</surname><given-names>G.K.</given-names></name></person-group>
<article-title>Inflammation, atherosclerosis, and coronary artery disease</article-title>
<source>N. Engl. J. Med.</source>
<year>2005</year>
<volume>352</volume>
<fpage>1685</fpage>
<lpage>1695</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra043430</pub-id>
<pub-id pub-id-type="pmid">15843671</pub-id></element-citation></ref><ref id="B86-ijms-15-13494"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pober</surname><given-names>J.S.</given-names></name><name><surname>Sessa</surname><given-names>W.C.</given-names></name></person-group>
<article-title>Evolving functions of endothelial cells in inflammation</article-title>
<source>Nat. Rev. Immunol.</source>
<year>2007</year>
<volume>7</volume>
<fpage>803</fpage>
<lpage>815</lpage>
<pub-id pub-id-type="doi">10.1038/nri2171</pub-id>
<pub-id pub-id-type="pmid">17893694</pub-id></element-citation></ref><ref id="B87-ijms-15-13494"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>T.A.</given-names></name><name><surname>Yamakuchi</surname><given-names>M.</given-names></name><name><surname>Ferlito</surname><given-names>M.</given-names></name><name><surname>Mendell</surname><given-names>J.T.</given-names></name><name><surname>Lowenstein</surname><given-names>C.J.</given-names></name></person-group>
<article-title>MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2008</year>
<volume>105</volume>
<fpage>1516</fpage>
<lpage>1521</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0707493105</pub-id>
<pub-id pub-id-type="pmid">18227515</pub-id></element-citation></ref><ref id="B88-ijms-15-13494"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.W.</given-names></name><name><surname>Hu</surname><given-names>Y.R.</given-names></name><name><surname>Zhao</surname><given-names>J.Y.</given-names></name><name><surname>Li</surname><given-names>S.F.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>S.G.</given-names></name><name><surname>Lu</surname><given-names>J.B.</given-names></name><name><surname>Qiu</surname><given-names>Y.R.</given-names></name><name><surname>Sha</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>Y.C.</given-names></name><etal/></person-group>
<article-title>An agomir of miR-144&#x02013;3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<fpage>e94997</fpage>
<pub-id pub-id-type="pmid">24733347</pub-id></element-citation></ref><ref id="B89-ijms-15-13494"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Finkel</surname><given-names>T.</given-names></name></person-group>
<article-title>Oxidant signals and oxidative stress</article-title>
<source>Curr. Opin. Cell Biol.</source>
<year>2003</year>
<volume>15</volume>
<fpage>247</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/S0955-0674(03)00002-4</pub-id>
<pub-id pub-id-type="pmid">12648682</pub-id></element-citation></ref><ref id="B90-ijms-15-13494"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Irani</surname><given-names>K.</given-names></name></person-group>
<article-title>Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling</article-title>
<source>Circ. Res.</source>
<year>2000</year>
<volume>87</volume>
<fpage>179</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1161/01.RES.87.3.179</pub-id>
<pub-id pub-id-type="pmid">10926866</pub-id></element-citation></ref><ref id="B91-ijms-15-13494"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madamanchi</surname><given-names>N.R.</given-names></name><name><surname>Vendrov</surname><given-names>A.</given-names></name><name><surname>Runge</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Oxidative stress and vascular disease</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2005</year>
<volume>25</volume>
<fpage>29</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">15539615</pub-id></element-citation></ref><ref id="B92-ijms-15-13494"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Napoli</surname><given-names>C.</given-names></name><name><surname>de Nigris</surname><given-names>F.</given-names></name><name><surname>Palinski</surname><given-names>W.</given-names></name></person-group>
<article-title>Multiple role of reactive oxygen species in the arterial wall</article-title>
<source>J. Cell. Biochem.</source>
<year>2001</year>
<volume>82</volume>
<fpage>674</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.1198</pub-id>
<pub-id pub-id-type="pmid">11500945</pub-id></element-citation></ref><ref id="B93-ijms-15-13494"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magenta</surname><given-names>A.</given-names></name><name><surname>Greco</surname><given-names>S.</given-names></name><name><surname>Gaetano</surname><given-names>C.</given-names></name><name><surname>Martelli</surname><given-names>F.</given-names></name></person-group>
<article-title>Oxidative stress and microRNAs in vascular diseases</article-title>
<source>Int. J. Mol. Sci.</source>
<year>2013</year>
<volume>14</volume>
<fpage>17319</fpage>
<lpage>17346</lpage>
<pub-id pub-id-type="doi">10.3390/ijms140917319</pub-id>
<pub-id pub-id-type="pmid">23975169</pub-id></element-citation></ref><ref id="B94-ijms-15-13494"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Thongboonkerd</surname><given-names>V.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Pierce</surname><given-names>W.M.</given-names><suffix>Jr.</suffix></name><name><surname>Klein</surname><given-names>J.B.</given-names></name><name><surname>Epstein</surname><given-names>P.N.</given-names></name></person-group>
<article-title>Cardiac mitochondrial damage and biogenesis in a chronic model of Type 1 diabetes</article-title>
<source>Am. J. Physiol. Endocrinol. Metab.</source>
<year>2004</year>
<volume>287</volume>
<fpage>E896</fpage>
<lpage>E905</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00047.2004</pub-id>
<pub-id pub-id-type="pmid">15280150</pub-id></element-citation></ref><ref id="B95-ijms-15-13494"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Villeneuve</surname><given-names>L.M.</given-names></name><name><surname>Reddy</surname><given-names>M.A.</given-names></name><name><surname>Lanting</surname><given-names>L.L.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Natarajan</surname><given-names>R.</given-names></name></person-group>
<article-title>Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2008</year>
<volume>105</volume>
<fpage>9047</fpage>
<lpage>9052</lpage>
<pub-id pub-id-type="pmid">18579779</pub-id></element-citation></ref><ref id="B96-ijms-15-13494"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alcendor</surname><given-names>R.R.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Zhai</surname><given-names>P.</given-names></name><name><surname>Zablocki</surname><given-names>D.</given-names></name><name><surname>Holle</surname><given-names>E.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>B.</given-names></name><name><surname>Wagner</surname><given-names>T.</given-names></name><name><surname>Vatner</surname><given-names>S.F.</given-names></name><name><surname>Sadoshima</surname><given-names>J.</given-names></name></person-group>
<article-title>Sirt1 regulates aging and resistance to oxidative stress in the heart</article-title>
<source>Circ. Res.</source>
<year>2007</year>
<volume>100</volume>
<fpage>1512</fpage>
<lpage>1521</lpage>
<pub-id pub-id-type="doi">10.1161/01.RES.0000267723.65696.4a</pub-id>
<pub-id pub-id-type="pmid">17446436</pub-id></element-citation></ref><ref id="B97-ijms-15-13494"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menghini</surname><given-names>R.</given-names></name><name><surname>Casagrande</surname><given-names>V.</given-names></name><name><surname>Cardellini</surname><given-names>M.</given-names></name><name><surname>Martelli</surname><given-names>E.</given-names></name><name><surname>Terrinoni</surname><given-names>A.</given-names></name><name><surname>Amati</surname><given-names>F.</given-names></name><name><surname>Vasa-Nicotera</surname><given-names>M.</given-names></name><name><surname>Ippoliti</surname><given-names>A.</given-names></name><name><surname>Novelli</surname><given-names>G.</given-names></name><name><surname>Melino</surname><given-names>G.</given-names></name><etal/></person-group>
<article-title>MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1</article-title>
<source>Circulation</source>
<year>2009</year>
<volume>120</volume>
<fpage>1524</fpage>
<lpage>1532</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.864629</pub-id>
<pub-id pub-id-type="pmid">19786632</pub-id></element-citation></ref><ref id="B98-ijms-15-13494"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Helgadottir</surname><given-names>A.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><name><surname>Manolescu</surname><given-names>A.</given-names></name><name><surname>Gretarsdottir</surname><given-names>S.</given-names></name><name><surname>Blondal</surname><given-names>T.</given-names></name><name><surname>Jonasdottir</surname><given-names>A.</given-names></name><name><surname>Jonasdottir</surname><given-names>A.</given-names></name><name><surname>Sigurdsson</surname><given-names>A.</given-names></name><name><surname>Baker</surname><given-names>A.</given-names></name><name><surname>Palsson</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>A common variant on chromosome 9p21 affects the risk of myocardial infarction</article-title>
<source>Science</source>
<year>2007</year>
<volume>316</volume>
<fpage>1491</fpage>
<lpage>1493</lpage>
<pub-id pub-id-type="doi">10.1126/science.1142842</pub-id>
<pub-id pub-id-type="pmid">17478679</pub-id></element-citation></ref><ref id="B99-ijms-15-13494"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McPherson</surname><given-names>R.</given-names></name><name><surname>Pertsemlidis</surname><given-names>A.</given-names></name><name><surname>Kavaslar</surname><given-names>N.</given-names></name><name><surname>Stewart</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name><name><surname>Cox</surname><given-names>D.R.</given-names></name><name><surname>Hinds</surname><given-names>D.A.</given-names></name><name><surname>Pennacchio</surname><given-names>L.A.</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A.</given-names></name><name><surname>Folsom</surname><given-names>A.R.</given-names></name><etal/></person-group>
<article-title>A common allele on chromosome 9 associated with coronary heart disease</article-title>
<source>Science</source>
<year>2007</year>
<volume>316</volume>
<fpage>1488</fpage>
<lpage>1491</lpage>
<pub-id pub-id-type="doi">10.1126/science.1142447</pub-id>
<pub-id pub-id-type="pmid">17478681</pub-id></element-citation></ref><ref id="B100-ijms-15-13494"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yap</surname><given-names>K.L.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Munoz-Cabello</surname><given-names>A.M.</given-names></name><name><surname>Raguz</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Mujtaba</surname><given-names>S.</given-names></name><name><surname>Gil</surname><given-names>J.</given-names></name><name><surname>Walsh</surname><given-names>M.J.</given-names></name><name><surname>Zhou</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a</article-title>
<source>Mol. Cell</source>
<year>2010</year>
<volume>38</volume>
<fpage>662</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2010.03.021</pub-id>
<pub-id pub-id-type="pmid">20541999</pub-id></element-citation></ref><ref id="B101-ijms-15-13494"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samani</surname><given-names>N.J.</given-names></name><name><surname>Erdmann</surname><given-names>J.</given-names></name><name><surname>Hall</surname><given-names>A.S.</given-names></name><name><surname>Hengstenberg</surname><given-names>C.</given-names></name><name><surname>Mangino</surname><given-names>M.</given-names></name><name><surname>Mayer</surname><given-names>B.</given-names></name><name><surname>Dixon</surname><given-names>R.J.</given-names></name><name><surname>Meitinger</surname><given-names>T.</given-names></name><name><surname>Braund</surname><given-names>P.</given-names></name><name><surname>Wichmann</surname><given-names>H.E.</given-names></name><etal/></person-group>
<article-title>Genomewide association analysis of coronary artery disease</article-title>
<source>N. Engl. J. Med.</source>
<year>2007</year>
<volume>357</volume>
<fpage>443</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa072366</pub-id>
<pub-id pub-id-type="pmid">17634449</pub-id></element-citation></ref><ref id="B102-ijms-15-13494"><label>102.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Folkersen</surname><given-names>L.</given-names></name><name><surname>Kyriakou</surname><given-names>T.</given-names></name><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Peden</surname><given-names>J.</given-names></name><name><surname>Malarstig</surname><given-names>A.</given-names></name><name><surname>Paulsson-Berne</surname><given-names>G.</given-names></name><name><surname>Hamsten</surname><given-names>A.</given-names></name><name><surname>Hugh</surname><given-names>W.</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A.</given-names></name><name><surname>Gabrielsen</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants</article-title>
<source>PLoS One</source>
<year>2009</year>
<volume>4</volume>
<fpage>e7677</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0007677</pub-id>
<pub-id pub-id-type="pmid">19888323</pub-id></element-citation></ref><ref id="B103-ijms-15-13494"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holdt</surname><given-names>L.M.</given-names></name><name><surname>Beutner</surname><given-names>F.</given-names></name><name><surname>Scholz</surname><given-names>M.</given-names></name><name><surname>Gielen</surname><given-names>S.</given-names></name><name><surname>Gabel</surname><given-names>G.</given-names></name><name><surname>Bergert</surname><given-names>H.</given-names></name><name><surname>Schuler</surname><given-names>G.</given-names></name><name><surname>Thiery</surname><given-names>J.</given-names></name><name><surname>Teupser</surname><given-names>D.</given-names></name></person-group>
<article-title>ANRIL expression is associated with atherosclerosis risk at chromosome 9p21</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2010</year>
<volume>30</volume>
<fpage>620</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.109.196832</pub-id>
<pub-id pub-id-type="pmid">20056914</pub-id></element-citation></ref><ref id="B104-ijms-15-13494"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holdt</surname><given-names>L.M.</given-names></name><name><surname>Teupser</surname><given-names>D.</given-names></name></person-group>
<article-title>Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2012</year>
<volume>32</volume>
<fpage>196</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.232678</pub-id>
<pub-id pub-id-type="pmid">22258902</pub-id></element-citation></ref><ref id="B105-ijms-15-13494"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cunnington</surname><given-names>M.S.</given-names></name><name><surname>Santibanez Koref</surname><given-names>M.</given-names></name><name><surname>Mayosi</surname><given-names>B.M.</given-names></name><name><surname>Burn</surname><given-names>J.</given-names></name><name><surname>Keavney</surname><given-names>B.</given-names></name></person-group>
<article-title>Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression</article-title>
<source>PLoS Genet.</source>
<year>2010</year>
<volume>6</volume>
<fpage>e1000899</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000899</pub-id>
<pub-id pub-id-type="pmid">20386740</pub-id></element-citation></ref><ref id="B106-ijms-15-13494"><label>106.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jarinova</surname><given-names>O.</given-names></name><name><surname>Stewart</surname><given-names>A.F.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name><name><surname>Wells</surname><given-names>G.</given-names></name><name><surname>Lau</surname><given-names>P.</given-names></name><name><surname>Naing</surname><given-names>T.</given-names></name><name><surname>Buerki</surname><given-names>C.</given-names></name><name><surname>McLean</surname><given-names>B.W.</given-names></name><name><surname>Cook</surname><given-names>R.C.</given-names></name><name><surname>Parker</surname><given-names>J.S.</given-names></name><etal/></person-group>
<article-title>Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2009</year>
<volume>29</volume>
<fpage>1671</fpage>
<lpage>1677</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.109.189522</pub-id>
<pub-id pub-id-type="pmid">19592466</pub-id></element-citation></ref><ref id="B107-ijms-15-13494"><label>107.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Sanoff</surname><given-names>H.K.</given-names></name><name><surname>Cho</surname><given-names>H.</given-names></name><name><surname>Burd</surname><given-names>C.E.</given-names></name><name><surname>Torrice</surname><given-names>C.</given-names></name><name><surname>Mohlke</surname><given-names>K.L.</given-names></name><name><surname>Ibrahim</surname><given-names>J.G.</given-names></name><name><surname>Thomas</surname><given-names>N.E.</given-names></name><name><surname>Sharpless</surname><given-names>N.E.</given-names></name></person-group>
<article-title>INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis</article-title>
<source>PLoS One</source>
<year>2009</year>
<volume>4</volume>
<fpage>e5027</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0005027</pub-id>
<pub-id pub-id-type="pmid">19343170</pub-id></element-citation></ref><ref id="B108-ijms-15-13494"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holdt</surname><given-names>L.M.</given-names></name><name><surname>Hoffmann</surname><given-names>S.</given-names></name><name><surname>Sass</surname><given-names>K.</given-names></name><name><surname>Langenberger</surname><given-names>D.</given-names></name><name><surname>Scholz</surname><given-names>M.</given-names></name><name><surname>Krohn</surname><given-names>K.</given-names></name><name><surname>Finstermeier</surname><given-names>K.</given-names></name><name><surname>Stahringer</surname><given-names>A.</given-names></name><name><surname>Wilfert</surname><given-names>W.</given-names></name><name><surname>Beutner</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks</article-title>
<source>PLoS Genet.</source>
<year>2013</year>
<volume>9</volume>
<fpage>e1003588</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003588</pub-id>
<pub-id pub-id-type="pmid">23861667</pub-id></element-citation></ref><ref id="B109-ijms-15-13494"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ellis</surname><given-names>B.C.</given-names></name><name><surname>Graham</surname><given-names>L.D.</given-names></name><name><surname>Molloy</surname><given-names>P.L.</given-names></name></person-group>
<article-title>CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism</article-title>
<source>Biochim. Biophys. Acta</source>
<year>2014</year>
<volume>1843</volume>
<fpage>372</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.10.016</pub-id>
<pub-id pub-id-type="pmid">24184209</pub-id></element-citation></ref><ref id="B110-ijms-15-13494"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ding</surname><given-names>G.L.</given-names></name><name><surname>Wang</surname><given-names>F.F.</given-names></name><name><surname>Shu</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia</article-title>
<source>Diabetes</source>
<year>2012</year>
<volume>61</volume>
<fpage>1133</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.2337/db11-1314</pub-id>
<pub-id pub-id-type="pmid">22447856</pub-id></element-citation></ref><ref id="B111-ijms-15-13494"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Metzger</surname><given-names>B.E.</given-names></name><name><surname>Buchanan</surname><given-names>T.A.</given-names></name><name><surname>Coustan</surname><given-names>D.R.</given-names></name><name><surname>de Leiva</surname><given-names>A.</given-names></name><name><surname>Dunger</surname><given-names>D.B.</given-names></name><name><surname>Hadden</surname><given-names>D.R.</given-names></name><name><surname>Hod</surname><given-names>M.</given-names></name><name><surname>Kitzmiller</surname><given-names>J.L.</given-names></name><name><surname>Kjos</surname><given-names>S.L.</given-names></name><name><surname>Oats</surname><given-names>J.N.</given-names></name><etal/></person-group>
<article-title>Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus</article-title>
<source>Diabetes Care</source>
<year>2007</year>
<volume>30</volume>
<issue>Suppl. 2</issue>
<fpage>S251</fpage>
<lpage>S260</lpage>
<pub-id pub-id-type="pmid">17596481</pub-id></element-citation></ref><ref id="B112-ijms-15-13494"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bateson</surname><given-names>P.</given-names></name><name><surname>Barker</surname><given-names>D.</given-names></name><name><surname>Clutton-Brock</surname><given-names>T.</given-names></name><name><surname>Deb</surname><given-names>D.</given-names></name><name><surname>D&#x02019;Udine</surname><given-names>B.</given-names></name><name><surname>Foley</surname><given-names>R.A.</given-names></name><name><surname>Gluckman</surname><given-names>P.</given-names></name><name><surname>Godfrey</surname><given-names>K.</given-names></name><name><surname>Kirkwood</surname><given-names>T.</given-names></name><name><surname>Lahr</surname><given-names>M.M.</given-names></name><etal/></person-group>
<article-title>Developmental plasticity and human health</article-title>
<source>Nature</source>
<year>2004</year>
<volume>430</volume>
<fpage>419</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1038/nature02725</pub-id>
<pub-id pub-id-type="pmid">15269759</pub-id></element-citation></ref><ref id="B113-ijms-15-13494"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moran</surname><given-names>I.</given-names></name><name><surname>Akerman</surname><given-names>I.</given-names></name><name><surname>van de Bunt</surname><given-names>M.</given-names></name><name><surname>Xie</surname><given-names>R.</given-names></name><name><surname>Benazra</surname><given-names>M.</given-names></name><name><surname>Nammo</surname><given-names>T.</given-names></name><name><surname>Arnes</surname><given-names>L.</given-names></name><name><surname>Nakic</surname><given-names>N.</given-names></name><name><surname>Garcia-Hurtado</surname><given-names>J.</given-names></name><name><surname>Rodriguez-Segui</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>Human &#x003b2; cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes</article-title>
<source>Cell Metab.</source>
<year>2012</year>
<volume>16</volume>
<fpage>435</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2012.08.010</pub-id>
<pub-id pub-id-type="pmid">23040067</pub-id></element-citation></ref><ref id="B114-ijms-15-13494"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ku</surname><given-names>G.M.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Vaughn</surname><given-names>I.W.</given-names></name><name><surname>Hangauer</surname><given-names>M.J.</given-names></name><name><surname>Myung Oh</surname><given-names>C.</given-names></name><name><surname>German</surname><given-names>M.S.</given-names></name><name><surname>McManus</surname><given-names>M.T.</given-names></name></person-group>
<article-title>Research resource: RNA-Seq reveals unique features of the pancreatic &#x003b2;-cell transcriptome</article-title>
<source>Mol. Endocrinol.</source>
<year>2012</year>
<volume>26</volume>
<fpage>1783</fpage>
<lpage>1792</lpage>
<pub-id pub-id-type="doi">10.1210/me.2012-1176</pub-id>
<pub-id pub-id-type="pmid">22915829</pub-id></element-citation></ref><ref id="B115-ijms-15-13494"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saltiel</surname><given-names>A.R.</given-names></name><name><surname>Kahn</surname><given-names>C.R.</given-names></name></person-group>
<article-title>Insulin signalling and the regulation of glucose and lipid metabolism</article-title>
<source>Nature</source>
<year>2001</year>
<volume>414</volume>
<fpage>799</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.1038/414799a</pub-id>
<pub-id pub-id-type="pmid">11742412</pub-id></element-citation></ref><ref id="B116-ijms-15-13494"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gregor</surname><given-names>M.F.</given-names></name><name><surname>Hotamisligil</surname><given-names>G.S.</given-names></name></person-group>
<article-title>Inflammatory mechanisms in obesity</article-title>
<source>Annu. Rev. Immunol.</source>
<year>2011</year>
<volume>29</volume>
<fpage>415</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101322</pub-id>
<pub-id pub-id-type="pmid">21219177</pub-id></element-citation></ref><ref id="B117-ijms-15-13494"><label>117.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glass</surname><given-names>C.K.</given-names></name><name><surname>Olefsky</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Inflammation and lipid signaling in the etiology of insulin resistance</article-title>
<source>Cell Metab.</source>
<year>2012</year>
<volume>15</volume>
<fpage>635</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2012.04.001</pub-id>
<pub-id pub-id-type="pmid">22560216</pub-id></element-citation></ref><ref id="B118-ijms-15-13494"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Gerin</surname><given-names>I.</given-names></name><name><surname>Miao</surname><given-names>H.</given-names></name><name><surname>Vu-Phan</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>C.N.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>X.W.</given-names></name><name><surname>Cawthorn</surname><given-names>W.P.</given-names></name><name><surname>MacDougald</surname><given-names>O.A.</given-names></name><name><surname>Koenig</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity</article-title>
<source>PLoS One</source>
<year>2010</year>
<volume>5</volume>
<fpage>e14199</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0014199</pub-id>
<pub-id pub-id-type="pmid">21152033</pub-id></element-citation></ref><ref id="B119-ijms-15-13494"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Goff</surname><given-names>L.A.</given-names></name><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Alexander</surname><given-names>R.</given-names></name><name><surname>Lo</surname><given-names>K.A.</given-names></name><name><surname>Hacisuleyman</surname><given-names>E.</given-names></name><name><surname>Sauvageau</surname><given-names>M.</given-names></name><name><surname>Tazon-Vega</surname><given-names>B.</given-names></name><name><surname>Kelley</surname><given-names>D.R.</given-names></name><name><surname>Hendrickson</surname><given-names>D.G.</given-names></name><etal/></person-group>
<article-title>Long noncoding RNAs regulate adipogenesis</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2013</year>
<volume>110</volume>
<fpage>3387</fpage>
<lpage>3392</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1222643110</pub-id>
<pub-id pub-id-type="pmid">23401553</pub-id></element-citation></ref><ref id="B120-ijms-15-13494"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Callegari</surname><given-names>E.</given-names></name><name><surname>Elamin</surname><given-names>B.K.</given-names></name><name><surname>Giannone</surname><given-names>F.</given-names></name><name><surname>Milazzo</surname><given-names>M.</given-names></name><name><surname>Altavilla</surname><given-names>G.</given-names></name><name><surname>Fornari</surname><given-names>F.</given-names></name><name><surname>Giacomelli</surname><given-names>L.</given-names></name><name><surname>D'Abundo</surname><given-names>L.</given-names></name><name><surname>Ferracin</surname><given-names>M.</given-names></name><name><surname>Bassi</surname><given-names>C.</given-names></name><etal/></person-group>
<article-title>Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model</article-title>
<source>Hepatology</source>
<year>2012</year>
<volume>56</volume>
<fpage>1025</fpage>
<lpage>1033</lpage>
<pub-id pub-id-type="pmid">22473819</pub-id></element-citation></ref><ref id="B121-ijms-15-13494"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bai</surname><given-names>S.</given-names></name><name><surname>Nasser</surname><given-names>M.W.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Hsu</surname><given-names>S.H.</given-names></name><name><surname>Datta</surname><given-names>J.</given-names></name><name><surname>Kutay</surname><given-names>H.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Nuovo</surname><given-names>G.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Ghoshal</surname><given-names>K.</given-names></name></person-group>
<article-title>MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib</article-title>
<source>J. Biol. Chem.</source>
<year>2009</year>
<volume>284</volume>
<fpage>32015</fpage>
<lpage>32027</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.016774</pub-id>
<pub-id pub-id-type="pmid">19726678</pub-id></element-citation></ref><ref id="B122-ijms-15-13494"><label>122.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tomimaru</surname><given-names>Y.</given-names></name><name><surname>Eguchi</surname><given-names>H.</given-names></name><name><surname>Nagano</surname><given-names>H.</given-names></name><name><surname>Wada</surname><given-names>H.</given-names></name><name><surname>Tomokuni</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Marubashi</surname><given-names>S.</given-names></name><name><surname>Takeda</surname><given-names>Y.</given-names></name><name><surname>Tanemura</surname><given-names>M.</given-names></name><name><surname>Umeshita</surname><given-names>K.</given-names></name><etal/></person-group>
<article-title>MicroRNA-21 induces resistance to the anti-tumour effect of interferon-&#x003b1;/5-fluorouracil in hepatocellular carcinoma cells</article-title>
<source>Br. J. Cancer</source>
<year>2010</year>
<volume>103</volume>
<fpage>1617</fpage>
<lpage>1626</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjc.6605958</pub-id>
<pub-id pub-id-type="pmid">20978511</pub-id></element-citation></ref><ref id="B123-ijms-15-13494"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Su</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><etal/></person-group>
<article-title>Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV</article-title>
<source>Mol. Cancer</source>
<year>2014</year>
<volume>13</volume>
<pub-id pub-id-type="doi">10.1186/1476-4598-13-127</pub-id>
</element-citation></ref><ref id="B124-ijms-15-13494"><label>124.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>K.J.</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C.</given-names></name><name><surname>Moore</surname><given-names>K.J.</given-names></name></person-group>
<article-title>MicroRNAs regulating lipid metabolism in atherogenesis</article-title>
<source>Thromb. Haemost.</source>
<year>2012</year>
<volume>107</volume>
<fpage>642</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1160/TH11-10-0694</pub-id>
<pub-id pub-id-type="pmid">22274626</pub-id></element-citation></ref><ref id="B125-ijms-15-13494"><label>125.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group>
<article-title>The Guideline of the design and validation of MiRNA mimics</article-title>
<source>Methods Mol. Biol.</source>
<year>2011</year>
<volume>676</volume>
<fpage>211</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-60761-863-8_15</pub-id>
<pub-id pub-id-type="pmid">20931400</pub-id></element-citation></ref><ref id="B126-ijms-15-13494"><label>126.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jamaluddin</surname><given-names>M.S.</given-names></name><name><surname>Weakley</surname><given-names>S.M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Kougias</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>P.H.</given-names></name><name><surname>Yao</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name></person-group>
<article-title>MiRNAs: Roles and clinical applications in vascular disease</article-title>
<source>Expert Rev. Mol. Diagn.</source>
<year>2011</year>
<volume>11</volume>
<fpage>79</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">21171923</pub-id></element-citation></ref><ref id="B127-ijms-15-13494"><label>127.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stenvang</surname><given-names>J.</given-names></name><name><surname>Petri</surname><given-names>A.</given-names></name><name><surname>Lindow</surname><given-names>M.</given-names></name><name><surname>Obad</surname><given-names>S.</given-names></name><name><surname>Kauppinen</surname><given-names>S.</given-names></name></person-group>
<article-title>Inhibition of microRNA function by antimiR oligonucleotides</article-title>
<source>Silence</source>
<year>2012</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.1186/1758-907X-3-1</pub-id>
</element-citation></ref><ref id="B128-ijms-15-13494"><label>128.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ebert</surname><given-names>M.S.</given-names></name><name><surname>Neilson</surname><given-names>J.R.</given-names></name><name><surname>Sharp</surname><given-names>P.A.</given-names></name></person-group>
<article-title>MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells</article-title>
<source>Nat. Methods</source>
<year>2007</year>
<volume>4</volume>
<fpage>721</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth1079</pub-id>
<pub-id pub-id-type="pmid">17694064</pub-id></element-citation></ref></ref-list></back></article>